AU2014280886A1 - Plants having enhanced yield-related traits and a method for making the same - Google Patents

Abstract

Abstract The present invention relates generally to the field of molecular biology and concerns a method for enhancing various economically important yield-related traits in plants. More specifically, the present invention concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding a DOF-C2 (DNA binding with one finger, subgroup C2) domain transcription factor polypeptide or a MYB7 polypeptide. The present invention also concerns plants having modulated expression of a nucleic acid encoding an a DOF-C2 domain transcription factor polypeptide or a MYB7 polypeptide, which plants have enhanced yield-related traits relative to control plants. The invention also provides constructs comprising the DOF-C2 domain transcription factor polypeptide or the MYB7 polypeptide, useful in performing the methods of the invention. 6068018_1 (GHMatters) P83714.AU.1 LEOWNR

Description

Plants having enhanced yield-related traits and a method for making the same The entire disclosure in the complete specification of our Australian Patent Application No. 2008320931 is by this cross-reference incorporated into the present specification. 5 The present invention relates generally to the field of molecular biology and concerns a method for enhancing yield-related traits or improving various plant growth characteristics by modulating expression in a plant of a nucleic acid encoding a DOF-C2 (DNA-binding with one finger, subgroup C2) domain transcription factor polypeptide or a MYB-domain protein J (MYB7). The present invention also concerns plants having modulated expression of a nucleic acid encoding a DOF-C2 domain transcription factor polypeptide or a MYB7 which plants have enhanced yield-related traits or improved growth characteristics relative to corresponding wild type plants or other control plants. The invention also provides constructs useful in the methods of the invention. 5 The ever-increasing world population and the dwindling supply of arable land available for agriculture fuels research towards increasing the efficiency of agriculture. Conventional means for crop and horticultural improvements utilise selective breeding techniques to identify plants having desirable characteristics. However, such selective breeding J techniques have several drawbacks, namely that these techniques are typically labour intensive and result in plants that often contain heterogeneous genetic components that may not always result in the desirable trait being passed on from parent plants. Advances in molecular biology have allowed mankind to modify the germplasm of animals and plants. Genetic engineering of plants entails the isolation and manipulation of genetic material 5 (typically in the form of DNA or RNA) and the subsequent introduction of that genetic material into a plant. Such technology has the capacity to deliver crops or plants having various improved economic, agronomic or horticultural traits. A trait of particular economic interest is increased yield. Yield is normally defined as the M0 measurable produce of economic value from a crop. This may be defined in terms of quantity and/or quality. Yield is directly dependent on several factors, for example, the number and size of the organs, plant architecture (for example, the number of branches), seed production, leaf senescence and more. Root development, nutrient uptake, stress tolerance and early vigour may also be important factors in determining yield. Optimizing 35 the abovementioned factors may therefore contribute to increasing crop yield. 1 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Seed yield is a particularly important trait, since the seeds of many plants are important for human and animal nutrition. Crops such as corn, rice, wheat, canola and soybean account for over half the total human caloric intake, whether through direct consumption of the seeds 5 themselves or through consumption of meat products raised on processed seeds. They are also a source of sugars, oils and many kinds of metabolites used in industrial processes. Seeds contain an embryo (the source of new shoots and roots) and an endosperm (the source of nutrients for embryo growth during germination and during early growth of seedlings). The development of a seed involves many genes, and requires the transfer of J metabolites from the roots, leaves and stems into the growing seed. The endosperm, in particular, assimilates the metabolic precursors of carbohydrates, oils and proteins and synthesizes them into storage macromolecules to fill out the grain. Another important trait for many crops is early vigour. Improving early vigour is an important 5 objective of modern rice breeding programs in both temperate and tropical rice cultivars. Long roots are important for proper soil anchorage in water-seeded rice. Where rice is sown directly into flooded fields, and where plants must emerge rapidly through water, longer shoots are associated with vigour. Where drill-seeding is practiced, longer mesocotyls and coleoptiles are important for good seedling emergence. The ability to engineer early vigour J into plants would be of great importance in agriculture. For example, poor early vigour has been a limitation to the introduction of maize (Zea mays L.) hybrids based on Corn Belt germplasm in the European Atlantic. A further important trait is that of improved abiotic stress tolerance. Abiotic stress is a 5 primary cause of crop loss worldwide, reducing average yields for most major crop plants by more than 50% (Wang et al., Planta (2003) 218: 1-14). Abiotic stresses may be caused by drought, salinity, extremes of temperature, chemical toxicity and oxidative stress. The ability to improve plant tolerance to abiotic stress would be of great economic advantage to farmers worldwide and would allow for the cultivation of crops during adverse conditions and in M0 territories where cultivation of crops may not otherwise be possible. Crop yield may therefore be increased by optimising one of the above-mentioned factors. Depending on the end use, the modification of certain yield traits may be favoured over 35 others. For example for applications such as forage or wood production, or bio-fuel resource, an increase in the vegetative parts of a plant may be desirable, and for 2 6022075_1 (GHMatters) P83714.AU.1 LEOWNR applications such as flour, starch or oil production, an increase in seed parameters may be particularly desirable. Even amongst the seed parameters, some may be favoured over others, depending on the application. Various mechanisms may contribute to increasing seed yield, whether that is in the form of increased seed size or increased seed number. 5 One approach to increasing yield (seed yield and/or biomass) in plants may be through modification of the inherent growth mechanisms of a plant, such as the cell cycle or various signalling pathways involved in plant growth or in defense mechanisms. J It has now been found that yield-related traits or various growth characteristics may be improved in plants by modulating expression in a plant of a nucleic acid encoding a DOF-C2 domain transcription factor polypeptide or a MYB7 in a plant. Dof domain proteins (proteins comprising a Dof domain) are plant-specific transcription 5 factors with a highly conserved DNA-binding domain with a single C2-C2 zinc finger. During the past decade, numerous Dof domain proteins have been identified in both monocots and dicots including maize, barley, wheat, rice, tobacco, Arabidopsis, pumpkin, potato and pea. Dof domain proteins have been shown to function as transcriptional activators or repressors in diverse plant-specific biological processes. Phylogenetic studies suggested that the Dof J domain proteins diverged before the diversification of Angiosperms, therefore after a long period of multiplication distinct Dof domain proteins could have evolved to play different roles in plant physiology. However the highly conserved sequence of the Dof domain may endow Dof domain proteins with similar function. On the other hand sequence of the Dof domain proteins are highly diverged outside of the Dof domain. It has been suggested that the 5 diversified regions outside the Dof domain might be linked to different functions of distinct Dof domain proteins (Yanagiswa, Plant Cell Physiol. 45(4): 386-391 (2004). Dof domain proteins display sequence-specific DNA binding activity. Sequence specificity is determined only by the Dof domain (Yanagisawa, S. (1995) Nucleic Acids Res. 23: 3403 30 3410; Kisu, Y., Ono, T., Shimofurutani, N., Suzuki, M. and Esaka, M. (1998) Plant Cell Physiol. 39: 1054-1064.). Binding sites in the targeted DNA have been described for numerous Dof proteins (Dof domain proteins) (De Paolis, A., Sabatini, S., de Pascalis, L., Contantino, P. and Capone, I. (1996) Plant J. 10: 215-223; Yanagisawa, S. and Izui, K. (1993) J. Biol. Chem. 268: 16028-16036; Mena, M., Vicente-Carbajosa, J., Schmidt, R.J. 35 and Carbonero, P. (1998) Plant J. 16: 53-62). Most Dof domain proteins bind the sequence AAAG or CTTT in complementary chain. An exception is found in the AOBP Dof domain 3 6022075_1 (GHMatters) P83714.AU.1 LEOWNR protein of pumkin that binds to the AGTA sequence (Kisu et al. 1998. Plant cell physiol 39, 1054-1064). The sequence (A/T) AAAG represents a recognized DNA binding core motif for Dof domains. 5 The Dof domain is composed about 50-60 amino acids comprising the consensus sequence CX2CX21CX2C, which is proposed to form a zinc finger structure similar to the Cys2/Cys2 zinc finger domains wherein the four conserved cystein residues would coordinate the zinc ions (Uemura et al. 2004 Plant J 37, 741-749. The Dof domain is enriched in basic amino acids. All Dof domains have four conserved cysteine residues, although the amino acid J sequence of the Dof domain and the arrangement of the cysteine residues differ from those of other zinc fingers (Yanagisawa, S. (1995) Nucleic Acids Res. 23: 3403-3410. Yanagisawa, S. (1996) Trends Plant Sci. 1: 213-214. Yanagisawa, S. (2002) Trends Plant Sci. 7: 555-560). 5 Arabidopsis and rice Dof domain proteins have been classified in 4 main orthologous clusters, named Aa, Bb, Cc and Dd (Lijavetzky et al. 2003. BMC Evolutionary Biology 3). Based on phylogenetic relations subclusters have been recognized within some of the main clusters. Outside of the Dof domain there is little sequence conservation amongst members in the different clusters. This large sequence diversity is suggestive of differentiated J biological roles for the Dof domain proteins in plants. However members within the same cluster or subcluster share a number of conserved sequence motifs, suggesting biological functional conservation for Dof proteins belonging to the same same cluster or subcluster. WO 2007/064724 discloses Dof domain proteins belonging to clusters Dd and Bb useful in 5 increasing plant yield. It is to be understood that, if any prior art publication is referred to herein, such reference does not constitute an admission that the publication forms a part of the common general knowledge in the art, in Australia or any other country. Summary In one embodiment, surprisingly, it has now been found that modulating expression of a nucleic acid encoding a Dof domain protein belonging to cluster Cc, subcluster C2 (DOF-C2 transcription factor polypeptide) gives plants having increased (or enhanced) yield relative to 35 suitable control plants. 4 6022075_1 (GHMatters) P83714.AU.1 LEOWNR According one embodiment, there is provided a method for improving yield-related traits of a plant relative to control plants, comprising modulating expression of a nucleic acid encoding a DOF-C2 domain transcription factor polypeptide in a plant. 5 MYB domain proteins are transcription factors with a highly conserved DNA-binding domain. The MYB domain was originally described in the oncogene (v-myb) of avian myeloblastosis virus (Klempnauer et al. (1982) Cell 33, 453-63). Many vertebrates contain three genes related to v-Myb c-Myb, A-Myb and B-Myb and other similar genes have been identified in J insects, plants, fungi and slime moulds. The encoded proteins are crucial to the control of proliferation and differentiation in a number of cell types. MYB proteins contain one to four imperfect direct repeats of a conserved sequence of 50-53 amino acids which encodes a helix-turn-helix structure involved in DNA binding (Rosinski and Atchley (1998) J Mol Evol 46, 74-83). Three regularly spaced tryptophan residues, which form a tryptophan cluster in 5 the three-dimensional helix-turn-helix structure, are characteristic of a MYB repeat. The three repeats in c-Myb are referred to as R1, R2 and R3; and repeats from other MYB proteins are categorised according to their similarity to R1, R2 or R3. Since there is little sequence conservation outside of the MYB domain, MYB proteins have been clustered into subgroups based on conserved motifs identified outside of the MYB coding region (Jiang et J al. (2004) Genome Biology 5, R46). AtMYB7 belongs to the R2R3-MYB gene family (Li and Parish, Plant J. 8, 963-972, 1995), which is a large gene family (with reportedly 126 genes in Arabidopsis thaliana (Zimmerman et al., Plant J. 40, 22-34, 2004)). Members of this group are involved in various processes, 5 including secondary metabolism, cell morphogenesis, regulation of meristem formation, flower and seed development, cell cycle, defense and stress responses, light and hormone signalling (Chen et al., Cell Res. 16, 797-798, 2006). Although AtMYB7 is reported to have increased expression under stress (Ma and Bohnert, Genome Biology 8:R49, 2007), its precise function in the plant is still unknown. It is furthermore postulated that AtMYB7 30 expression plays a role in biotic stress tolerance (WO 02/16655 and WO 03/000898). WO 2007099096 discloses a rice MYB protein useful for increasing seed yield in plants. In another embodiment, surprisingly, it has been found that modulating expression of a nucleic acid encoding a MYB7 polypeptide gives plants having enhanced yield-related traits, 35 in particular increased vegetative biomass and increased emergence vigour relative to control plants. 5 6022075_1 (GHMatters) P83714.AU.1 LEOWNR According to another embodiment, there is provided a method for improving yield related traits of a plant relative to control plants, comprising modulating expression of a nucleic acid encoding a MYB7 polypeptide in a plant. The improved yield related traits comprised 5 increased biomass and increased emergence vigour. Definitions Comprising J In the claims which follow and in the description of the invention, except where the context requires otherwise due to express language or necessary implication, the word "comprise" or variations such as "comprises" or "comprising" is used in an inclusive sense, i.e. to specify the presence of the stated features but not to preclude the presence or addition of further features in various embodiments of the invention. 5 Polypeptide(s)/Protein(s) The terms "polypeptide" and "protein" are used interchangeably herein and refer to amino acids in a polymeric form of any length, linked together by peptide bonds. J Polynucleotide(s)/Nucleic acid(s)/Nucleic acid sequence(s)/nucleotide sequence(s) The terms "polynucleotide(s)", "nucleic acid sequence(s)", "nucleotide sequence(s)", "nucleic acid(s)", "nucleic acid molecule" are used interchangeably herein and refer to nucleotides, either ribonucleotides or deoxyribonucleotides or a combination of both, in a polymeric unbranched form of any length. 5 Control plant(s) The choice of suitable control plants is a routine part of an experimental setup and may include corresponding wild type plants or corresponding plants without the gene of interest. The control plant is typically of the same plant species or even of the same variety as the M0 plant to be assessed. The control plant may also be a nullizygote of the plant to be assessed. Nullizygotes are individuals missing the transgene by segregation. A "control plant" as used herein refers not only to whole plants, but also to plant parts, including seeds and seed parts. 6 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Homoloque(s) "Homologues" of a protein encompass peptides, oligopeptides, polypeptides, proteins and enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified protein in question and having similar biological and functional activity as the 5 unmodified protein from which they are derived. A deletion refers to removal of one or more amino acids from a protein. An insertion refers to one or more amino acid residues being introduced into a J predetermined site in a protein. Insertions may comprise N-terminal and/or C-terminal fusions as well as intra-sequence insertions of single or multiple amino acids. Generally, insertions within the amino acid sequence will be smaller than N- or C-terminal fusions, of the order of about 1 to 10 residues. Examples of N- or C-terminal fusion proteins or peptides include the binding domain or activation domain of a transcriptional activator as 5 used in the yeast two-hybrid system, phage coat proteins, (histidine)-6-tag, glutathione S transferase-tag, protein A, maltose-binding protein, dihydrofolate reductase, Tag-100 epitope, c-myc epitope, FLAG*-epitope, lacZ, CMP (calmodulin-binding peptide), HA epitope, protein C epitope and VSV epitope. J A substitution refers to replacement of amino acids of the protein with other amino acids having similar properties (such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break a-helical structures or p-sheet structures). Amino acid substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the polypeptide; insertions will usually be of the order of 5 about 1 to 10 amino acid residues. The amino acid substitutions are preferably conservative amino acid substitutions. Conservative substitution tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company (Eds) and Table 1 below). Table 1: Examples of conserved amino acid substitutions Residue Conservative Substitutions Residue Conservative Substitutions Ala Ser Leu lie; Val Arg Lys Lys Arg; GIn Asn GIn; His Met Leu; Ile Asp Glu Phe Met; Leu; Tyr GIn Asn Ser Thr; Gly Cys Ser Thr Ser; Val 7 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Glu Asp Trp Tyr Gly Pro Tyr Trp; Phe His Asn; Gin Val lie; Leu Ile Leu, Val Amino acid substitutions, deletions and/or insertions may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulation. Methods for the manipulation of DNA sequences 5 to produce substitution, insertion or deletion variants of a protein are well known in the art. For example, techniques for making substitution mutations at predetermined sites in DNA are well known to those skilled in the art and include M13 mutagenesis, T7-Gen in vitro mutagenesis (USB, Cleveland, OH), QuickChange Site Directed mutagenesis (Stratagene, San Diego, CA), PCR-mediated site-directed mutagenesis or other site-directed J mutagenesis protocols. Derivatives "Derivatives" include peptides, oligopeptides, polypeptides which may, compared to the amino acid sequence of the naturally-occurring form of the protein, such as the protein of 5 interest, comprise substitutions of amino acids with non-naturally occurring amino acid residues, or additions of non-naturally occurring amino acid residues. "Derivatives" of a protein also encompass peptides, oligopeptides, polypeptides which comprise naturally occurring altered (glycosylated, acylated, prenylated, phosphorylated, myristoylated, sulphated etc.) or non-naturally altered amino acid residues compared to the amino acid 0 sequence of a naturally-occurring form of the polypeptide. A derivative may also comprise one or more non-amino acid substituents or additions compared to the amino acid sequence from which it is derived, for example a reporter molecule or other ligand, covalently or non covalently bound to the amino acid sequence, such as a reporter molecule which is bound to facilitate its detection, and non-naturally occurring amino acid residues relative to the amino 5 acid sequence of a naturally-occurring protein. Furthermore, "derivatives" also include fusions of the naturally-occurring form of the protein with tagging peptides such as FLAG, HIS6 or thioredoxin (for a review of tagging peptides, see Terpe, Appl. Microbiol. Biotechnol. 60, 523-533, 2003). 30 Ortholoque(s)/Paraloque(s) Orthologues and paralogues encompass evolutionary concepts used to describe the ancestral relationships of genes. Paralogues are genes within the same species that have 8 6022075_1 (GHMatters) P83714.AU.1 LEOWNR originated through duplication of an ancestral gene; orthologues are genes from different organisms that have originated through speciation, and are also derived from a common ancestral gene. 5 Domain The term "domain" refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are likely essential in the structure, stability or function of J a protein. Identified by their high degree of conservation in aligned sequences of a family of protein homologues, they can be used as identifiers to determine if any polypeptide in question belongs to a previously identified polypeptide family. Motif/Consensus sequence/Signature 5 The term "motif' or "consensus sequence" or "signature" refers to a short conserved region in the sequence of evolutionarily related proteins. Motifs are frequently highly conserved parts of domains, but may also include only part of the domain, or be located outside of conserved domain (if all of the amino acids of the motif fall outside of a defined domain). J Hybridisation The term "hybridisation" as defined herein is a process wherein substantially homologous complementary nucleotide sequences anneal to each other. The hybridisation process can occur entirely in solution, i.e. both complementary nucleic acids are in solution. The hybridisation process can also occur with one of the complementary nucleic acids 5 immobilised to a matrix such as magnetic beads, Sepharose beads or any other resin. The hybridisation process can furthermore occur with one of the complementary nucleic acids immobilised to a solid support such as a nitro-cellulose or nylon membrane or immobilised by e.g. photolithography to, for example, a siliceous glass support (the latter known as nucleic acid arrays or microarrays or as nucleic acid chips). In order to allow hybridisation to 30 occur, the nucleic acid molecules are generally thermally or chemically denatured to melt a double strand into two single strands and/or to remove hairpins or other secondary structures from single stranded nucleic acids. The term "stringency" refers to the conditions under which a hybridisation takes place. The 35 stringency of hybridisation is influenced by conditions such as temperature, salt concentration, ionic strength and hybridisation buffer composition. Generally, low stringency 9 6022075_1 (GHMatters) P83714.AU.1 LEOWNR conditions are selected to be about 300C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. Medium stringency conditions are when the temperature is 200C below Tm, and high stringency conditions are when the temperature is 100C below Tm. High stringency hybridisation conditions are typically used 5 for isolating hybridising sequences that have high sequence similarity to the target nucleic acid sequence. However, nucleic acids may deviate in sequence and still encode a substantially identical polypeptide, due to the degeneracy of the genetic code. Therefore medium stringency hybridisation conditions may sometimes be needed to identify such nucleic acid molecules. D The Tm is the temperature under defined ionic strength and pH, at which 50% of the target sequence hybridises to a perfectly matched probe. The Tm is dependent upon the solution conditions and the base composition and length of the probe. For example, longer sequences hybridise specifically at higher temperatures. The maximum rate of hybridisation 5 is obtained from about 160C up to 320C below Tm. The presence of monovalent cations in the hybridisation solution reduce the electrostatic repulsion between the two nucleic acid strands thereby promoting hybrid formation; this effect is visible for sodium concentrations of up to 0.4M (for higher concentrations, this effect may be ignored). Formamide reduces the melting temperature of DNA-DNA and DNA-RNA duplexes with 0.6 to 0.70C for each D percent formamide, and addition of 50% formamide allows hybridisation to be performed at 30 to 450C, though the rate of hybridisation will be lowered. Base pair mismatches reduce the hybridisation rate and the thermal stability of the duplexes. On average and for large probes, the Tm decreases about 10C per % base mismatch. The Tm may be calculated using the following equations, depending on the types of hybrids: 5 1) DNA-DNA hybrids (Meinkoth and Wahl, Anal. Biochem., 138: 267-284, 1984): Tm= 81.50C + 16.6xlogio[Na+]a + 0.41x%[G/Cb] - 500x[Lc]l - 0.61x% formamide 2) DNA-RNA or RNA-RNA hybrids: Tm= 79.8 + 18.5 (logio[Na+]a) + 0.58 (%G/Cb) + 11.8 (%G/Cb) 2 - 820/Lc 30 3) oligo-DNA or oligo-RNAd hybrids: For <20 nucleotides: Tm= 2 (In) For 20-35 nucleotides: Tm= 22 + 1.46 (In) a or for other monovalent cation, but only accurate in the 0.01-0.4 M range. b only accurate for %GC in the 30% to 75% range. 35 C L = length of duplex in base pairs. d oligo, oligonucleotide; In, = effective length of primer = 2x(no. of G/C)+(no. of A/T). 10 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Non-specific binding may be controlled using any one of a number of known techniques such as, for example, blocking the membrane with protein containing solutions, additions of heterologous RNA, DNA, and SDS to the hybridisation buffer, and treatment with Rnase. 5 For non-homologous probes, a series of hybridizations may be performed by varying one of (i) progressively lowering the annealing temperature (for example from 680C to 420C) or (ii) progressively lowering the formamide concentration (for example from 50% to 0%). The skilled artisan is aware of various parameters which may be altered during hybridisation and which will either maintain or change the stringency conditions. Besides the hybridisation conditions, specificity of hybridisation typically also depends on the function of post-hybridisation washes. To remove background resulting from non-specific hybridisation, samples are washed with dilute salt solutions. Critical factors of such washes include the ionic strength and temperature of the final wash solution: the lower the salt 5 concentration and the higher the wash temperature, the higher the stringency of the wash. Wash conditions are typically performed at or below hybridisation stringency. A positive hybridisation gives a signal that is at least twice of that of the background. Generally, suitable stringent conditions for nucleic acid hybridisation assays or gene amplification detection procedures are as set forth above. More or less stringent conditions may also be J selected. The skilled artisan is aware of various parameters which may be altered during washing and which will either maintain or change the stringency conditions. For example, typical high stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 650C in 1x SSC or at 420C in 1x SSC and 50% 5 formamide, followed by washing at 650C in 0.3x SSC. Examples of medium stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 500C in 4x SSC or at 400C in 6x SSC and 50% formamide, followed by washing at 500C in 2x SSC. The length of the hybrid is the anticipated length for the hybridising nucleic acid. When nucleic acids of known sequence are hybridised, the hybrid 30 length may be determined by aligning the sequences and identifying the conserved regions described herein. 1xSSC is 0.15M NaCl and 15mM sodium citrate; the hybridisation solution and wash solutions may additionally include 5x Denhardt's reagent, 0.5-1.0% SDS, 100 pg/ml denatured, fragmented salmon sperm DNA, 0.5% sodium pyrophosphate. 35 For the purposes of defining the level of stringency, reference can be made to Sambrook et al. (2001) Molecular Cloning: a laboratory manual, 3 rd Edition, Cold Spring Harbor 11 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Laboratory Press, CSH, New York or to Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989 and yearly updates). Splice variant 5 The term "splice variant" as used herein encompasses variants of a nucleic acid sequence in which selected introns and/or exons have been excised, replaced, displaced or added, or in which introns have been shortened or lengthened. Such variants will be ones in which the biological activity of the protein is substantially retained; this may be achieved by selectively retaining functional segments of the protein. Such splice variants may be found in nature or J may be manmade. Methods for predicting and isolating such splice variants are well known in the art (see for example Foissac and Schiex (2005) BMC Bioinformatics 6: 25). Allelic variant Alleles or allelic variants are alternative forms of a given gene, located at the same 5 chromosomal position. Allelic variants encompass Single Nucleotide Polymorphisms (SNPs), as well as Small Insertion/Deletion Polymorphisms (INDELs). The size of INDELs is usually less than 100 bp. SNPs and INDELs form the largest set of sequence variants in naturally occurring polymorphic strains of most organisms. J Gene shuffling/Directed evolution Gene shuffling or directed evolution consists of iterations of DNA shuffling followed by appropriate screening and/or selection to generate variants of nucleic acids or portions thereof encoding proteins having a modified biological activity (Castle et al., (2004) Science 304(5674): 1151-4; US patents 5,811,238 and 6,395,547). 5 Regulatory element/Control sequence/Promoter The terms "regulatory element", "control sequence" and "promoter" are all used interchangeably herein and are to be taken in a broad context to refer to regulatory nucleic acid sequences capable of effecting expression of the sequences to which they are ligated. 30 The term "promoter" typically refers to a nucleic acid control sequence located upstream from the transcriptional start of a gene and which is involved in recognising and binding of RNA polymerase and other proteins, thereby directing transcription of an operably linked nucleic acid. Encompassed by the aforementioned terms are transcriptional regulatory sequences derived from a classical eukaryotic genomic gene (including the TATA box which 35 is required for accurate transcription initiation, with or without a CCAAT box sequence) and additional regulatory elements (i.e. upstream activating sequences, enhancers and 12 6022075_1 (GHMatters) P83714.AU.1 LEOWNR silencers) which alter gene expression in response to developmental and/or external stimuli, or in a tissue-specific manner. Also included within the term is a transcriptional regulatory sequence of a classical prokaryotic gene, in which case it may include a -35 box sequence and/or -10 box transcriptional regulatory sequences. The term "regulatory element" also 5 encompasses a synthetic fusion molecule or derivative that confers, activates or enhances expression of a nucleic acid molecule in a cell, tissue or organ. A "plant promoter" comprises regulatory elements, which mediate the expression of a coding sequence segment in plant cells. Accordingly, a plant promoter need not be of plant origin, J but may originate from viruses or micro-organisms, for example from viruses which attack plant cells. The "plant promoter" can also originate from a plant cell, e.g. from the plant which is transformed with the nucleic acid sequence to be expressed in the inventive process and described herein. This also applies to other "plant" regulatory signals, such as "plant" terminators. The promoters upstream of the nucleotide sequences useful in the 5 methods of the present invention can be modified by one or more nucleotide substitution(s), insertion(s) and/or deletion(s) without interfering with the functionality or activity of either the promoters, the open reading frame (ORF) or the 3'-regulatory region such as terminators or other 3' regulatory regions which are located away from the ORF. It is furthermore possible that the activity of the promoters is increased by modification of their sequence, or that they J are replaced completely by more active promoters, even promoters from heterologous organisms. For expression in plants, the nucleic acid molecule must, as described above, be linked operably to or comprise a suitable promoter which expresses the gene at the right point in time and with the required spatial expression pattern. 5 For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assaying the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta-galactosidase. The promoter activity is assayed by M0 measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid used in the methods of the present invention, with mRNA levels of 35 housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT 13 6022075_1 (GHMatters) P83714.AU.1 LEOWNR PCR (Heid et al., 1996 Genome Methods 6: 986-994). Generally by "weak promoter" is intended a promoter that drives expression of a coding sequence at a low level. By "low level" is intended at levels of about 1/10,000 transcripts to about 1/100,000 transcripts, to about 1/500,0000 transcripts per cell. Conversely, a "strong promoter" drives expression of 5 a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1000 transcripts per cell. Operably linked The term "operably linked" as used herein refers to a functional linkage between the J promoter sequence and the gene of interest, such that the promoter sequence is able to initiate transcription of the gene of interest. Constitutive promoter A "constitutive promoter" refers to a promoter that is transcriptionally active during most, but 5 not necessarily all, phases of growth and development and under most environmental conditions, in at least one cell, tissue or organ. Table 2C below gives examples of constitutive promoters. Ubiquitous promoter J A ubiquitous promoter is active in substantially all tissues or cells of an organism. Developmentally-regulated promoter A developmentally-regulated promoter is active during certain developmental stages or in parts of the plant that undergo developmental changes. 5 Inducible promoter An inducible promoter has induced or increased transcription initiation in response to a chemical (for a review see Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108), environmental or physical stimulus, or may be "stress-inducible", i.e. activated when a plant 30 is exposed to various stress conditions, or a "pathogen-inducible" i.e. activated when a plant is exposed to exposure to various pathogens. Orqan-specific/Tissue-specific promoter An organ-specific or tissue-specific promoter is one that is capable of preferentially initiating 35 transcription in certain organs or tissues, such as the leaves, roots, seed tissue etc. For example, a "root-specific promoter" is a promoter that is transcriptionally active 14 6022075_1 (GHMatters) P83714.AU.1 LEOWNR predominantly in plant roots, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. Promoters able to initiate transcription in certain cells only are referred to herein as "cell-specific". 5 Examples of root-specific promoters are listed in Table 2A below: Table 2A: Examples of root-specific promoters Gene Source Reference RCc3 Plant Mol Biol. 1995 Jan;27(2):237-48 Arabidopsis PHT1 Kovama et al., 2005; Mudge et al. (2002, Plant J. 31:341) Medicago phosphate Xiao et al., 2006 transporter Arabidopsis Pyk10 Nitz et al. (2001) Plant Sci 161(2): 337-346 root-expressible genes Tingey et al., EMBO J. 6: 1, 1987. tobacco auxin-inducible Van der Zaal et al., Plant Mol. Biol. 16, 983, 1991. gene p-tubulin Oppenheimer, et al., Gene 63: 87, 1988. tobacco root-specific genes Conkling, et al., Plant Physiol. 93: 1203, 1990. B. napus G1-3b gene United States Patent No. 5, 401, 836 SbPRP1 Suzuki et al., Plant Mol. Biol. 21: 109-119, 1993. LRX1 Baumberger et al. 2001, Genes & Dev. 15:1128 BTG-26 Brassica napus US 20050044585 LeAMT1 (tomato) Lauter et al. (1996, PNAS 3:8139) The LeNRT1-1 (tomato) Lauter et al. (1996, PNAS 3:8139) class I patatin gene (potato) Liu et al., Plant Mol. Biol. 153:386-395, 1991. KDC1 (Daucus carota) Downey et al. (2000, J. Biol. Chem. 275:39420) TobRB7 gene W Song (1997) PhD Thesis, North Carolina State University, Raleigh, NC USA OsRAB5a (rice) Wang et al. 2002, Plant Sci. 163:273 ALF5 (Arabidopsis) Diener et al. (2001, Plant Cell 13:1625) NRT2;1Np (N. Quesada et al. (1997, Plant Mol. Biol. 34:265) plumbaginifolia) A seed-specific promoter is transcriptionally active predominantly in seed tissue, but not necessarily exclusively in seed tissue (in cases of leaky expression). The seed-specific 0 promoter may be active during seed development and/or during germination. Examples of 15 6022075_1 (GHMatters) P83714.AU.1 LEOWNR seed-specific promoters are shown in Table 2B below. Further examples of seed-specific promoters are given in Qing Qu and Takaiwa (Plant Biotechnol. J. 2, 113-125, 2004), which disclosure is incorporated by reference herein as if fully set forth. 5 Table 2B: Examples of seed-specific promoters Gene source Reference seed-specific genes Simon et al., Plant Mol. Biol. 5: 191, 1985; Scofield et al., J. Biol. Chem. 262: 12202, 1987.; Baszczynski et al., Plant Mol. Biol. 14: 633, 1990. Brazil Nut albumin Pearson et al., Plant Mol. Biol. 18: 235-245, 1992. legumin Ellis et al., Plant Mol. Biol. 10: 203-214, 1988. glutelin (rice) Takaiwa et al., Mol. Gen. Genet. 208: 15-22, 1986; Takaiwa et al., FEBS Letts. 221: 43-47, 1987. zein Matzke et al Plant Mol Biol, 14(3):323-32 1990 napA Stalberg et al, Planta 199: 515-519, 1996. wheat LMW and HMW glutenin-1 Mol Gen Genet 216:81-90, 1989; NAR 17:461-2, 1989 wheat SPA Albani et al, Plant Cell, 9: 171-184, 1997 wheat a, P, y-gliadins EMBO J. 3:1409-15, 1984 barley Itr1 promoter Diaz et al. (1995) Mol Gen Genet 248(5):592-8 barley B1, C, D, hordein Theor Appl Gen 98:1253-62, 1999; Plant J 4:343-55, 1993; Mol Gen Genet 250:750-60, 1996 barley DOF Mena et al, The Plant Journal, 116(1): 53-62, 1998 blz2 EP99106056.7 synthetic promoter Vicente-Carbajosa et al., Plant J. 13: 629-640, 1998. rice prolamin NRP33 Wu et al, Plant Cell Physiology 39(8) 885-889, 1998 rice a-globulin Glb-1 Wu et al, Plant Cell Physiology 39(8) 885-889, 1998 rice OSH1 Sato et al, Proc. Natl. Acad. Sci. USA, 93: 8117-8122, 1996 rice a-globulin REB/OHP-1 Nakase et al. Plant Mol. Biol. 33: 513-522, 1997 rice ADP-glucose pyrophos- Trans Res 6:157-68, 1997 phorylase maize ESR gene family Plant J 12:235-46, 1997 sorghum a-kafirin DeRose et al., Plant Mol. Biol 32:1029-35, 1996 KNOX Postma-Haarsma et al, Plant Mol. Biol. 39:257-71, 1999 rice oleosin Wu et al, J. Biochem. 123:386, 1998 16 6022075_1 (GHMatters) P83714.AU.1 LEOWNR sunflower oleosin Cummins et al., Plant Mol. Biol. 19: 873-876, 1992 PRO01 17, putative rice 40S WO 2004/070039 ribosomal protein PROO136, rice alanine unpublished aminotransferase PRO0147, trypsin inhibitor ITR1 unpublished (barley) PROO1 51, rice WSI 18 WO 2004/070039 PROO175, rice RAB21 WO 2004/070039 PROO05 WO 2004/070039 PRO0095 WO 2004/070039 a-amylase (Amy32b) Lanahan et al, Plant Cell 4:203-211, 1992; Skriver et al, Proc Natl Acad Sci USA 88:7266-7270, 1991 cathepsin p-like gene Cejudo et al, Plant Mol Biol 20:849-856, 1992 Barley Ltp2 Kalla et al., Plant J. 6:849-60, 1994 Chi26 Leah et al., Plant J. 4:579-89, 1994 Maize B-Peru Selinger et al., Genetics 149; 1125-38,1998 A green tissue-specific promoter as defined herein is a promoter that is transcriptionally active predominantly in green tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. 5 Table 2C: Examples of constitutive promoters Gene Source Reference Actin McElroy et al, Plant Cell, 2: 163-171, 1990 HMGP WO 2004/070039 CAMV 35S Odell et al, Nature, 313: 810-812, 1985 CaMV 19S Nilsson et al., Physiol. Plant. 100:456-462, 1997 GOS2 de Pater et al, Plant J Nov;2(6):837-44, 1992, WO 2004/065596 Ubiquitin Christensen et al, Plant Mol. Biol. 18: 675-689, 1992 Rice cyclophilin Buchholz et al, Plant Mol Biol. 25(5): 837-43, 1994 Maize H3 histone Lepetit et al, Mol. Gen. Genet. 231:276-285, 1992 Alfalfa H3 histone Wu et al. Plant Mol. Biol. 11:641-649, 1988 Actin 2 An et al, Plant J. 10(1); 107-121, 1996 34S FMV Sanger et al., Plant. Mol. Biol., 14, 1990: 433-443 17 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Rubisco small subunit US 4,962,028 OCS Leisner (1988) Proc Natl Acad Sci USA 85(5): 2553 SAD1 Jain et al., Crop Science, 39 (6), 1999: 1696 SAD2 Jain et al., Crop Science, 39 (6), 1999: 1696 nos Shaw et al. (1984) Nucleic Acids Res. 12(20):7831-7846 V-ATPase WO 01/14572 Super promoter WO 95/14098 G-box proteins WO 94/12015 Another example of a tissue-specific promoter is a meristem-specific promoter, which is transcriptionally active predominantly in meristematic tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant 5 parts. Terminator The term "terminator" encompasses a control sequence which is a DNA sequence at the end of a transcriptional unit which signals 3' processing and polyadenylation of a primary J transcript and termination of transcription. The terminator can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The terminator to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. 5 Modulation The term "modulation" means in relation to expression or gene expression, a process in which the expression level is changed by said gene expression in comparison to the control plant, the expression level may be increased or decreased. The original, unmodulated expression may be of any kind of expression of a structural RNA (rRNA, tRNA) or mRNA 0 with subsequent translation. The term "modulating the activity" shall mean any change of the expression of the inventive nucleic acid sequences or encoded proteins, which leads to increased yield and/or increased growth of the plants. Expression 5 The term "expression" or "gene expression" means the transcription of a specific gene or specific genes or specific genetic construct. The term "expression" or "gene expression" in particular means the transcription of a gene or genes or genetic construct into structural 18 6022075_1 (GHMatters) P83714.AU.1 LEOWNR RNA (rRNA, tRNA) or mRNA with or without subsequent translation of the latter into a protein. The process includes transcription of DNA and processing of the resulting mRNA product. 5 Increased expression/overexpression The term "increased expression" or "overexpression" as used herein means any form of expression that is additional to the original wild-type expression level. Methods for increasing expression of genes or gene products are well documented in the art J and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression of a nucleic acid encoding the polypeptide of interest. For example, endogenous promoters 5 may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, US 5,565,350; Zarling et al., W09322443), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene. J If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3'-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3' end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from 5 any other eukaryotic gene. An intron sequence may also be added to the 5' untranslated region (UTR) or the coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both 30 plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg (1988) Mol. Cell biol. 8: 4395-4405; Callis et al. (1987) Genes Dev 1:1183-1200). Such intron enhancement of gene expression is typically greatest when placed near the 5' end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. 35 For general information see: The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994). 19 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Endogenous gene Reference herein to an "endogenous" gene not only refers to the gene in question as found in a plant in its natural form (i.e., without there being any human intervention), but also refers 5 to that same gene (or a substantially homologous nucleic acid/gene) in an isolated form subsequently (re)introduced into a plant (a transgene). For example, a transgenic plant containing such a transgene may encounter a substantial reduction of the transgene expression and/or substantial reduction of expression of the endogenous gene. The isolated gene may be isolated from an organism or may be manmade, for example by chemical J synthesis. Decreased expression Reference herein to "decreased epression" or "reduction or substantial elimination" of expression is taken to mean a decrease in endogenous gene expression and/or polypeptide 5 levels and/or polypeptide activity relative to control plants. The reduction or substantial elimination is in increasing order of preference at least 10%, 20%, 30%, 40% or 50%, 60%, 70%, 80%, 85%, 90%, or 95%, 96%, 97%, 98%, 99% or more reduced compared to that of control plants. J For the reduction or substantial elimination of expression an endogenous gene in a plant, a sufficient length of substantially contiguous nucleotides of a nucleic acid sequence is required. In order to perform gene silencing, this may be as little as 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10 or fewer nucleotides, alternatively this may be as much as the entire gene (including the 5' and/or 3' UTR, either in part or in whole). The stretch of substantially 5 contiguous nucleotides may be derived from the nucleic acid encoding the protein of interest (target gene), or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest. Preferably, the stretch of substantially contiguous nucleotides is capable of forming hydrogen bonds with the target gene (either sense or antisense strand), more preferably, the stretch of substantially contiguous nucleotides has, M0 in increasing order of preference, 50%, 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100% sequence identity to the target gene (either sense or antisense strand). A nucleic acid sequence encoding a (functional) polypeptide is not a requirement for the various methods discussed herein for the reduction or substantial elimination of expression of an endogenous gene. 35 20 6022075_1 (GHMatters) P83714.AU.1 LEOWNR This reduction or substantial elimination of expression may be achieved using routine tools and techniques. A preferred method for the reduction or substantial elimination of endogenous gene expression is by introducing and expressing in a plant a genetic construct into which the nucleic acid (in this case a stretch of substantially contiguous nucleotides 5 derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of any one of the protein of interest) is cloned as an inverted repeat (in part or completely), separated by a spacer (non-coding DNA). In such a preferred method, expression of the endogenous gene is reduced or substantially J eliminated through RNA-mediated silencing using an inverted repeat of a nucleic acid or a part thereof (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest), preferably capable of forming a hairpin structure. The inverted repeat is cloned in an expression vector comprising control sequences. A non 5 coding DNA nucleic acid sequence (a spacer, for example a matrix attachment region fragment (MAR), an intron, a polylinker, etc.) is located between the two inverted nucleic acids forming the inverted repeat. After transcription of the inverted repeat, a chimeric RNA with a self-complementary structure is formed (partial or complete). This double-stranded RNA structure is referred to as the hairpin RNA (hpRNA). The hpRNA is processed by the D plant into siRNAs that are incorporated into an RNA-induced silencing complex (RISC). The RISC further cleaves the mRNA transcripts, thereby substantially reducing the number of mRNA transcripts to be translated into polypeptides. For further general details see for example, Grierson et al. (1998) WO 98/53083; Waterhouse et al. (1999) WO 99/53050). 5 Performance of the methods of the invention does not rely on introducing and expressing in a plant a genetic construct into which the nucleic acid is cloned as an inverted repeat, but any one or more of several well-known "gene silencing" methods may be used to achieve the same effects. 30 One such method for the reduction of endogenous gene expression is RNA-mediated silencing of gene expression (downregulation). Silencing in this case is triggered in a plant by a double stranded RNA sequence (dsRNA) that is substantially similar to the target endogenous gene. This dsRNA is further processed by the plant into about 20 to about 26 nucleotides called short interfering RNAs (siRNAs). The siRNAs are incorporated into an 35 RNA-induced silencing complex (RISC) that cleaves the mRNA transcript of the endogenous target gene, thereby substantially reducing the number of mRNA transcripts to be translated 21 6022075_1 (GHMatters) P83714.AU.1 LEOWNR into a polypeptide. Preferably, the double stranded RNA sequence corresponds to a target gene. Another example of an RNA silencing method involves the introduction of nucleic acid 5 sequences or parts thereof (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest) in a sense orientation into a plant. "Sense orientation" refers to a DNA sequence that is homologous to an mRNA transcript thereof. Introduced into a plant would therefore be at least one copy of the nucleic J acid sequence. The additional nucleic acid sequence will reduce expression of the endogenous gene, giving rise to a phenomenon known as co-suppression. The reduction of gene expression will be more pronounced if several additional copies of a nucleic acid sequence are introduced into the plant, as there is a positive correlation between high transcript levels and the triggering of co-suppression. 5 Another example of an RNA silencing method involves the use of antisense nucleic acid sequences. An "antisense" nucleic acid sequence comprises a nucleotide sequence that is complementary to a "sense" nucleic acid sequence encoding a protein, i.e. complementary to the coding strand of a double-stranded cDNA molecule or complementary to an mRNA J transcript sequence. The antisense nucleic acid sequence is preferably complementary to the endogenous gene to be silenced. The complementarity may be located in the "coding region" and/or in the "non-coding region" of a gene. The term "coding region" refers to a region of the nucleotide sequence comprising codons that are translated into amino acid residues. The term "non-coding region" refers to 5' and 3' sequences that flank the coding 5 region that are transcribed but not translated into amino acids (also referred to as 5' and 3' untranslated regions). Antisense nucleic acid sequences can be designed according to the rules of Watson and Crick base pairing. The antisense nucleic acid sequence may be complementary to the M0 entire nucleic acid sequence (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest), but may also be an oligonucleotide that is antisense to only a part of the nucleic acid sequence (including the mRNA 5' and 3' UTR). For example, the antisense oligonucleotide sequence may be 35 complementary to the region surrounding the translation start site of an mRNA transcript encoding a polypeptide. The length of a suitable antisense oligonucleotide sequence is 22 6022075_1 (GHMatters) P83714.AU.1 LEOWNR known in the art and may start from about 50, 45, 40, 35, 30, 25, 20, 15 or 10 nucleotides in length or less. An antisense nucleic acid sequence according to the invention may be constructed using chemical synthesis and enzymatic ligation reactions using methods known in the art. For example, an antisense nucleic acid sequence (e.g., an antisense 5 oligonucleotide sequence) may be chemically synthesized using naturally occurring nucleotides or variously modified nucleotides designed to increase the biological stability of the molecules or to increase the physical stability of the duplex formed between the antisense and sense nucleic acid sequences, e.g., phosphorothioate derivatives and acridine substituted nucleotides may be used. Examples of modified nucleotides that may J be used to generate the antisense nucleic acid sequences are well known in the art. Known nucleotide modifications include methylation, cyclization and 'caps' and substitution of one or more of the naturally occurring nucleotides with an analogue such as inosine. Other modifications of nucleotides are well known in the art. 5 The antisense nucleic acid sequence can be produced biologically using an expression vector into which a nucleic acid sequence has been subcloned in an antisense orientation (i.e., RNA transcribed from the inserted nucleic acid will be of an antisense orientation to a target nucleic acid of interest). Preferably, production of antisense nucleic acid sequences in plants occurs by means of a stably integrated nucleic acid construct comprising a J promoter, an operably linked antisense oligonucleotide, and a terminator. The nucleic acid molecules used for silencing in the methods of the invention (whether introduced into a plant or generated in situ) hybridize with or bind to mRNA transcripts and/or genomic DNA encoding a polypeptide to thereby inhibit expression of the protein, 5 e.g., by inhibiting transcription and/or translation. The hybridization can be by conventional nucleotide complementarity to form a stable duplex, or, for example, in the case of an antisense nucleic acid sequence which binds to DNA duplexes, through specific interactions in the major groove of the double helix. Antisense nucleic acid sequences may be introduced into a plant by transformation or direct injection at a specific tissue site. M0 Alternatively, antisense nucleic acid sequences can be modified to target selected cells and then administered systemically. For example, for systemic administration, antisense nucleic acid sequences can be modified such that they specifically bind to receptors or antigens expressed on a selected cell surface, e.g., by linking the antisense nucleic acid sequence to peptides or antibodies which bind to cell surface receptors or antigens. The antisense 35 nucleic acid sequences can also be delivered to cells using the vectors described herein. 23 6022075_1 (GHMatters) P83714.AU.1 LEOWNR According to a further aspect, the antisense nucleic acid sequence is an a-anomeric nucleic acid sequence. An a-anomeric nucleic acid sequence forms specific double-stranded hybrids with complementary RNA in which, contrary to the usual b-units, the strands run parallel to each other (Gaultier et al. (1987) Nucl Ac Res 15: 6625-6641). The antisense 5 nucleic acid sequence may also comprise a 2'-o-methylribonucleotide (Inoue et al. (1987) Nucl Ac Res 15, 6131-6148) or a chimeric RNA-DNA analogue (Inoue et al. (1987) FEBS Lett. 215, 327-330). The reduction or substantial elimination of endogenous gene expression may also be J performed using ribozymes. Ribozymes are catalytic RNA molecules with ribonuclease activity that are capable of cleaving a single-stranded nucleic acid sequence, such as an mRNA, to which they have a complementary region. Thus, ribozymes (e.g., hammerhead ribozymes (described in Haselhoff and Gerlach (1988) Nature 334, 585-591) can be used to catalytically cleave mRNA transcripts encoding a polypeptide, thereby substantially reducing 5 the number of mRNA transcripts to be translated into a polypeptide. A ribozyme having specificity for a nucleic acid sequence can be designed (see for example: Cech et al. U.S. Patent No. 4,987,071; and Cech et al. U.S. Patent No. 5,116,742). Alternatively, mRNA transcripts corresponding to a nucleic acid sequence can be used to select a catalytic RNA having a specific ribonuclease activity from a pool of RNA molecules (Bartel and Szostak J (1993) Science 261, 1411-1418). The use of ribozymes for gene silencing in plants is known in the art (e.g., Atkins et al. (1994) WO 94/00012; Lenne et al. (1995) WO 95/03404; Lutziger et al. (2000) WO 00/00619; Prinsen et al. (1997) WO 97/13865 and Scott et al. (1997) WO 97/38116). 5 Gene silencing may also be achieved by insertion mutagenesis (for example, T-DNA insertion or transposon insertion) or by strategies as described by, among others, Angell and Baulcombe ((1999) Plant J 20(3): 357-62), (Amplicon VIGS WO 98/36083), or Baulcombe (WO 99/15682). M0 Gene silencing may also occur if there is a mutation on an endogenous gene and/or a mutation on an isolated gene/nucleic acid subsequently introduced into a plant. The reduction or substantial elimination may be caused by a non-functional polypeptide. For example, the polypeptide may bind to various interacting proteins; one or more mutation(s) and/or truncation(s) may therefore provide for a polypeptide that is still able to bind 35 interacting proteins (such as receptor proteins) but that cannot exhibit its normal function (such as signalling ligand). 24 6022075_1 (GHMatters) P83714.AU.1 LEOWNR A further approach to gene silencing is by targeting nucleic acid sequences complementary to the regulatory region of the gene (e.g., the promoter and/or enhancers) to form triple helical structures that prevent transcription of the gene in target cells. See Helene, C., 5 Anticancer Drug Res. 6, 569-84, 1991; Helene et al., Ann. N.Y. Acad. Sci. 660, 27-36 1992; and Maher, L.J. Bioassays 14, 807-15, 1992. Other methods, such as the use of antibodies directed to an endogenous polypeptide for inhibiting its function in planta, or interference in the signalling pathway in which a J polypeptide is involved, will be well known to the skilled man. In particular, it can be envisaged that manmade molecules may be useful for inhibiting the biological function of a target polypeptide, or for interfering with the signalling pathway in which the target polypeptide is involved. 5 Alternatively, a screening program may be set up to identify in a plant population natural variants of a gene, which variants encode polypeptides with reduced activity. Such natural variants may also be used for example, to perform homologous recombination. Artificial and/or natural microRNAs (miRNAs) may be used to knock out gene expression J and/or mRNA translation. Endogenous miRNAs are single stranded small RNAs of typically 19-24 nucleotides long. They function primarily to regulate gene expression and/ or mRNA translation. Most plant microRNAs (miRNAs) have perfect or near-perfect complementarity with their target sequences. However, there are natural targets with up to five mismatches. They are processed from longer non-coding RNAs with characteristic fold-back structures by 5 double-strand specific RNases of the Dicer family. Upon processing, they are incorporated in the RNA-induced silencing complex (RISC) by binding to its main component, an Argonaute protein. MiRNAs serve as the specificity components of RISC, since they base pair to target nucleic acids, mostly mRNAs, in the cytoplasm. Subsequent regulatory events include target mRNA cleavage and destruction and/or translational inhibition. Effects of 30 miRNA overexpression are thus often reflected in decreased mRNA levels of target genes. Artificial microRNAs (amiRNAs), which are typically 21 nucleotides in length, can be genetically engineered specifically to negatively regulate gene expression of single or multiple genes of interest. Determinants of plant microRNA target selection are well known 35 in the art. Empirical parameters for target recognition have been defined and can be used to aid in the design of specific amiRNAs, (Schwab et al., Dev. Cell 8, 517-527, 2005). 25 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Convenient tools for design and generation of amiRNAs and their precursors are also available to the public (Schwab et al., Plant Cell 18, 1121-1133, 2006). For optimal performance, the gene silencing techniques used for reducing expression in a 5 plant of an endogenous gene requires the use of nucleic acid sequences from monocotyledonous plants for transformation of monocotyledonous plants, and from dicotyledonous plants for transformation of dicotyledonous plants. Preferably, a nucleic acid sequence from any given plant species is introduced into that same species. For example, a nucleic acid sequence from rice is transformed into a rice plant. However, it is not an J absolute requirement that the nucleic acid sequence to be introduced originates from the same plant species as the plant in which it will be introduced. It is sufficient that there is substantial homology between the endogenous target gene and the nucleic acid to be introduced. 5 Described above are examples of various methods for the reduction or substantial elimination of expression in a plant of an endogenous gene. A person skilled in the art would readily be able to adapt the aforementioned methods for silencing so as to achieve reduction of expression of an endogenous gene in a whole plant or in parts thereof through the use of an appropriate promoter, for example. Selectable marker (gene)/Reporter gene "Selectable marker", "selectable marker gene" or "reporter gene" includes any gene that confers a phenotype on a cell in which it is expressed to facilitate the identification and/or selection of cells that are transfected or transformed with a nucleic acid construct of the 5 invention. These marker genes enable the identification of a successful transfer of the nucleic acid molecules via a series of different principles. Suitable markers may be selected from markers that confer antibiotic or herbicide resistance, that introduce a new metabolic trait or that allow visual selection. Examples of selectable marker genes include genes conferring resistance to antibiotics (such as nptll that phosphorylates neomycin and M0 kanamycin, or hpt, phosphorylating hygromycin, or genes conferring resistance to, for example, bleomycin, streptomycin, tetracyclin, chloramphenicol, ampicillin, gentamycin, geneticin (G418), spectinomycin or blasticidin), to herbicides (for example bar which provides resistance to Basta*; aroA or gox providing resistance against glyphosate, or the genes conferring resistance to, for example, imidazolinone, phosphinothricin or 35 sulfonylurea), or genes that provide a metabolic trait (such as manA that allows plants to use mannose as sole carbon source or xylose isomerase for the utilisation of xylose, or 26 6022075_1 (GHMatters) P83714.AU.1 LEOWNR antinutritive markers such as the resistance to 2-deoxyglucose). Expression of visual marker genes results in the formation of colour (for example p-glucuronidase, GUS or p galactosidase with its coloured substrates, for example X-Gal), luminescence (such as the luciferin/luceferase system) or fluorescence (Green Fluorescent Protein, GFP, and 5 derivatives thereof). This list represents only a small number of possible markers. The skilled worker is familiar with such markers. Different markers are preferred, depending on the organism and the selection method. It is known that upon stable or transient integration of nucleic acids into plant cells, only a D minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional 5 by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides of the invention or used in the methods of the invention, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid can be identified for example by selection (for example, cells D which have integrated the selectable marker survive whereas the other cells die). Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process according to the invention for introducing the 5 nucleic acids advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises M0 (up to 40% or more of the transformants), both vectors. In case of transformation with Agrobacteria, the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together 35 with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid 27 6022075_1 (GHMatters) P83714.AU.1 LEOWNR construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing 5 crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Crel is a recombinase that removes the sequences located between the loxP sequences. If the J marker gene is integrated between the loxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is 5 possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria. Transgenic/Transgene/Recombinant For the purposes of the invention, "transgenic", "transgene" or "recombinant" means with J regard to, for example, a nucleic acid sequence, an expression cassette, gene construct or a vector comprising the nucleic acid sequence or an organism transformed with the nucleic acid sequences, expression cassettes or vectors according to the invention, all those constructions brought about by recombinant methods in which either (a) the nucleic acid sequences encoding proteins useful in the methods of the invention, 5 or (b) genetic control sequence(s) which is operably linked with the nucleic acid sequence according to the invention, for example a promoter, or (c) a) and b) are not located in their natural genetic environment or have been modified by recombinant M0 methods, it being possible for the modification to take the form of, for example, a substitution, addition, deletion, inversion or insertion of one or more nucleotide residues. The natural genetic environment is understood as meaning the natural genomic or chromosomal locus in the original plant or the presence in a genomic library. In the case of a genomic library, the natural genetic environment of the nucleic acid sequence is preferably 35 retained, at least in part. The environment flanks the nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp, especially 28 6022075_1 (GHMatters) P83714.AU.1 LEOWNR preferably at least 1000 bp, most preferably at least 5000 bp. A naturally occurring expression cassette - for example the naturally occurring combination of the natural promoter of the nucleic acid sequences with the corresponding nucleic acid sequence encoding a polypeptide useful in the methods of the present invention, as defined above 5 becomes a transgenic expression cassette when this expression cassette is modified by non-natural, synthetic ("artificial") methods such as, for example, mutagenic treatment. Suitable methods are described, for example, in US 5,565,350 or WO 00/15815. A transgenic plant for the purposes of the invention is thus understood as meaning, as J above, that the nucleic acids used in the method of the invention are not at their natural locus in the genome of said plant, it being possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also means that, while the nucleic acids according to the invention or used in the inventive method are at their natural position in the genome of a plant, the sequence has been modified with regard to the 5 natural sequence, and/or that the regulatory sequences of the natural sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression of the nucleic acids takes place. Preferred transgenic plants are mentioned herein. Transformation The term "introduction" or "transformation" as referred to herein encompasses the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer. Plant tissue capable of subsequent clonal propagation, whether by organogenesis or 5 embryogenesis, may be transformed with a genetic construct of the present invention and a whole plant regenerated there from. The particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed. Exemplary tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical M0 meristem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem). The polynucleotide may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host genome. The resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to 35 persons skilled in the art. 29 6022075_1 (GHMatters) P83714.AU.1 LEOWNR The transfer of foreign genes into the genome of a plant is called transformation. Transformation of plant species is now a fairly routine technique. Advantageously, any of several transformation methods may be used to introduce the gene of interest into a suitable ancestor cell. The methods described for the transformation and regeneration of plants from 5 plant tissues or plant cells may be utilized for transient or for stable transformation. Transformation methods include the use of liposomes, electroporation, chemicals that increase free DNA uptake, injection of the DNA directly into the plant, particle gun bombardment, transformation using viruses or pollen and microprojection. Methods may be selected from the calcium/polyethylene glycol method for protoplasts (Krens, F.A. et al., D (1982) Nature 296, 72-74; Negrutiu I et al. (1987) Plant Mol Biol 8: 363-373); electroporation of protoplasts (Shillito R.D. et al. (1985) Bio/Technol 3, 1099-1102); microinjection into plant material (Crossway A et al., (1986) Mol. Gen Genet 202: 179-185); DNA or RNA-coated particle bombardment (Klein TM et al., (1987) Nature 327: 70) infection with (non-integrative) viruses and the like. Transgenic plants, including transgenic crop plants, are preferably 5 produced via Agrobacterium-mediated transformation. An advantageous transformation method is the transformation in planta. To this end, it is possible, for example, to allow the agrobacteria to act on plant seeds or to inoculate the plant meristem with agrobacteria. It has proved particularly expedient in accordance with the invention to allow a suspension of transformed agrobacteria to act on the intact plant or at least on the flower primordia. The D plant is subsequently grown on until the seeds of the treated plant are obtained (Clough and Bent, Plant J. (1998) 16, 735-743). Methods for Agrobacterium-mediated transformation of rice include well known methods for rice transformation, such as those described in any of the following: European patent application EP 1198985 Al, Aldemita and Hodges (Planta 199: 612-617, 1996); Chan et al. (Plant Mol Biol 22 (3): 491-506, 1993), Hiei et al. (Plant J 6 5 (2): 271-282, 1994), which disclosures are incorporated by reference herein as if fully set forth. In the case of corn transformation, the preferred method is as described in either Ishida et al. (Nat. Biotechnol 14(6): 745-50, 1996) or Frame et al. (Plant Physiol 129(1): 13 22, 2002), which disclosures are incorporated by reference herein as if fully set forth. Said methods are further described by way of example in B. Jenes et al., Techniques for Gene 30 Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S.D. Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225). The nucleic acids or the construct to be expressed is preferably cloned into a vector, which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711). Agrobacteria transformed 35 by such a vector can then be used in known manner for the transformation of plants, such as plants used as a model, like Arabidopsis (Arabidopsis thaliana is within the scope of the 30 6022075_1 (GHMatters) P83714.AU.1 LEOWNR present invention not considered as a crop plant), or crop plants such as, by way of example, tobacco plants, for example by immersing bruised leaves or chopped leaves in an agrobacterial solution and then culturing them in suitable media. The transformation of plants by means of Agrobacterium tumefaciens is described, for example, by H6fgen and 5 Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known inter alia from F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38. In addition to the transformation of somatic cells, which then have to be regenerated into J intact plants, it is also possible to transform the cells of plant meristems and in particular those cells which develop into gametes. In this case, the transformed gametes follow the natural plant development, giving rise to transgenic plants. Thus, for example, seeds of Arabidopsis are treated with agrobacteria and seeds are obtained from the developing plants of which a certain proportion is transformed and thus transgenic [Feldman, KA and 5 Marks MD (1987). Mol Gen Genet 208:274-289; Feldmann K (1992). In: C Koncz, N-H Chua and J Shell, eds, Methods in Arabidopsis Research. Word Scientific, Singapore, pp. 274 289]. Alternative methods are based on the repeated removal of the inflorescences and incubation of the excision site in the center of the rosette with transformed agrobacteria, whereby transformed seeds can likewise be obtained at a later point in time (Chang (1994). J Plant J. 5: 551-558; Katavic (1994). Mol Gen Genet, 245: 363-370). However, an especially effective method is the vacuum infiltration method with its modifications such as the "floral dip" method. In the case of vacuum infiltration of Arabidopsis, intact plants under reduced pressure are treated with an agrobacterial suspension [Bechthold, N (1993). C R Acad Sci Paris Life Sci, 316: 1194-1199], while in the case of the "floral dip" method the developing 5 floral tissue is incubated briefly with a surfactant-treated agrobacterial suspension [Clough, SJ and Bent AF (1998) The Plant J. 16, 735-743]. A certain proportion of transgenic seeds are harvested in both cases, and these seeds can be distinguished from non-transgenic seeds by growing under the above-described selective conditions. In addition the stable transformation of plastids is of advantages because plastids are inherited maternally is most 30 crops reducing or eliminating the risk of transgene flow through pollen. The transformation of the chloroplast genome is generally achieved by a process which has been schematically displayed in Klaus et al., 2004 [Nature Biotechnology 22 (2), 225-229]. Briefly the sequences to be transformed are cloned together with a selectable marker gene between flanking sequences homologous to the chloroplast genome. These homologous flanking 35 sequences direct site specific integration into the plastome. Plastidal transformation has been described for many different plant species and an overview is given in Bock (2001) 31 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Transgenic plastids in basic research and plant biotechnology. J Mol Biol. 2001 Sep 21; 312 (3):425-38 or Maliga, P (2003) Progress towards commercialization of plastid transformation technology. Trends Biotechnol. 21, 20-28. Further biotechnological progress has recently been reported in form of marker free plastid transformants, which can be produced by a 5 transient co-integrated maker gene (Klaus et al., 2004, Nature Biotechnology 22(2), 225 229). T-DNA activation taqqing T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), involves insertion of T J DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is 5 typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through Agrobacterium infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter. J TILLING The term "TILLING" is an abbreviation of "Targeted Induced Local Lesions In Genomes" and refers to a mutagenesis technology useful to generate and/or identify nucleic acids encoding proteins with modified expression and/or activity. TILLING also allows selection of plants carrying such mutant variants. These mutant variants may exhibit modified expression, 5 either in strength or in location or in timing (if the mutations affect the promoter for example). These mutant variants may exhibit higher activity than that exhibited by the gene in its natural form. TILLING combines high-density mutagenesis with high-throughput screening methods. The steps typically followed in TILLING are: (a) EMS mutagenesis (Redei GP and Koncz C (1992) In Methods in Arabidopsis Research, Koncz C, Chua NH, Schell J, eds. 30 Singapore, World Scientific Publishing Co, pp. 16-82; Feldmann et al., (1994) In Meyerowitz EM, Somerville CR, eds, Arabidopsis. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 137-172; Lightner J and Caspar T (1998) In J Martinez-Zapater, J Salinas, eds, Methods on Molecular Biology, Vol. 82. Humana Press, Totowa, NJ, pp 91-104); (b) DNA preparation and pooling of individuals; (c) PCR amplification of a region of interest; (d) 35 denaturation and annealing to allow formation of heteroduplexes; (e) DHPLC, where the presence of a heteroduplex in a pool is detected as an extra peak in the chromatogram; (f) 32 6022075_1 (GHMatters) P83714.AU.1 LEOWNR identification of the mutant individual; and (g) sequencing of the mutant PCR product. Methods for TILLING are well known in the art (McCallum et al., (2000) Nat Biotechnol 18: 455-457; reviewed by Stemple (2004) Nat Rev Genet 5(2): 145-50). 5 Homologous recombination Homologous recombination allows introduction in a genome of a selected nucleic acid at a defined selected position. Homologous recombination is a standard technology used routinely in biological sciences for lower organisms such as yeast or the moss Physcomitrella. Methods for performing homologous recombination in plants have been J described not only for model plants (Offringa et al. (1990) EMBO J 9(10): 3077-84) but also for crop plants, for example rice (Terada et al. (2002) Nat Biotech 20(10): 1030-4; lida and Terada (2004) Curr Opin Biotech 15(2): 132-8), and approaches exist that are generally applicable regardless of the target organism (Miller et al, Nature Biotechnol. 25, 778-785, 2007). 5 Yield The term "yield" in general means a measurable produce of economic value, typically related to a specified crop, to an area, and to a period of time. Individual plant parts directly contribute to yield based on their number, size and/or weight, or the actual yield is the yield J per square meter for a crop and year, which is determined by dividing total production (includes both harvested and appraised production) by planted square meters. The term "yield" of a plant may relate to vegetative biomass (root and/or shoot biomass), to reproductive organs, and/or to propagules (such as seeds) of that plant. 5 Early vigour "Early vigour" refers to active healthy well-balanced growth especially during early stages of plant growth, and may result from increased plant fitness due to, for example, the plants being better adapted to their environment (i.e. optimizing the use of energy resources and partitioning between shoot and root). Plants having early vigour also show increased 30 seedling survival and a better establishment of the crop, which often results in highly uniform fields (with the crop growing in uniform manner, i.e. with the majority of plants reaching the various stages of development at substantially the same time), and often better and higher yield. Therefore, early vigour may be determined by measuring various factors, such as thousand kernel weight, percentage germination, percentage emergence, seedling growth, 35 seedling height, root length, root and shoot biomass and many more. 33 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Increase/I m prove/Enhance The terms "increase", "improve" or "enhance" are interchangeable and shall mean in the sense of the application at least a 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10%, preferably at least 15% or 20%, more preferably 25%, 30%, 35% or 40% more yield and/or growth in 5 comparison to control plants as defined herein. Seed yield Increased seed yield may manifest itself as one or more of the following: a) an increase in seed biomass (total seed weight) which may be on an individual seed basis and/or per plant J and/or per square meter; b) increased number of flowers per plant; c) increased number of (filled) seeds; d) increased seed filling rate (which is expressed as the ratio between the number of filled seeds divided by the total number of seeds); e) increased harvest index, which is expressed as a ratio of the yield of harvestable parts, such as seeds, divided by the total biomass; and f) increased thousand kernel weight (TKW), which is extrapolated from 5 the number of filled seeds counted and their total weight. An increased TKW may result from an increased seed size and/or seed weight, and may also result from an increase in embryo and/or endosperm size. An increase in seed yield may also be manifested as an increase in seed size and/or seed D volume. Furthermore, an increase in seed yield may also manifest itself as an increase in seed area and/or seed length and/or seed width and/or seed perimeter. Increased yield may also result in modified architecture, or may occur because of modified architecture. Greenness Index 5 The "greenness index" as used herein is calculated from digital images of plants. For each pixel belonging to the plant object on the image, the ratio of the green value versus the red value (in the RGB model for encoding color) is calculated. The greenness index is expressed as the percentage of pixels for which the green-to-red ratio exceeds a given threshold. Under normal growth conditions, under salt stress growth conditions, and under M0 reduced nutrient availability growth conditions, the greenness index of plants is measured in the last imaging before flowering. In contrast, under drought stress growth conditions, the greenness index of plants is measured in the first imaging after drought. Plant 35 The term "plant" as used herein encompasses whole plants, ancestors and progeny of the plants and plant parts, including seeds, shoots, stems, leaves, roots (including tubers), 34 6022075_1 (GHMatters) P83714.AU.1 LEOWNR flowers, and tissues and organs, wherein each of the aforementioned comprise the gene/nucleic acid of interest. The term "plant" also encompasses plant cells, suspension cultures, callus tissue, embryos, meristematic regions, gametophytes, sporophytes, pollen and microspores, again wherein each of the aforementioned comprises the gene/nucleic 5 acid of interest. Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs J selected from the list comprising Acer spp., Actinidia spp., Abelmoschus spp., Agave sisalana, Agropyron spp., Agrostis stolonifera, Allium spp., Amaranthus spp., Ammophila arenaria, Ananas comosus, Annona spp., Apium graveolens, Arachis spp, Artocarpus spp., Asparagus officinalis, Avena spp. (e.g. Avena sativa, Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena hybrida), Averrhoa carambola, Bambusa sp., Benincasa hispida, 5 Bertholletia excelsea, Beta vulgaris, Brassica spp. (e.g. Brassica napus, Brassica rapa ssp. [canola, oilseed rape, turnip rape]), Cadaba farinosa, Camellia sinensis, Canna indica, Cannabis sativa, Capsicum spp., Carex elata, Carica papaya, Carissa macrocarpa, Carya spp., Carthamus tinctorius, Castanea spp., Ceiba pentandra, Cichorium endivia, Cinnamomum spp., Citrullus lanatus, Citrus spp., Cocos spp., Coffea spp., Colocasia 3 esculenta, Cola spp., Corchorus sp., Coriandrum sativum, Corylus spp., Crataegus spp., Crocus sativus, Cucurbita spp., Cucumis spp., Cynara spp., Daucus carota, Desmodium spp., Dimocarpus longan, Dioscorea spp., Diospyros spp., Echinochloa spp., Elaeis (e.g. Elaeis guineensis, Elaeis oleifera), Eleusine coracana, Erianthus sp., Eriobotrya japonica, Eucalyptus sp., Eugenia uniflora, Fagopyrum spp., Fagus spp., Festuca arundinacea, Ficus 5 carica, Fortunella spp., Fragaria spp., Ginkgo biloba, Glycine spp. (e.g. Glycine max, Soja hispida or Soja max), Gossypium hirsutum, Helianthus spp. (e.g. Helianthus annuus), Hemerocallis fulva, Hibiscus spp., Hordeum spp. (e.g. Hordeum vulgare), lpomoea batatas, Juglans spp., Lactuca sativa, Lathyrus spp., Lens culinaris, Linum usitatissimum, Litchi chinensis, Lotus spp., Luffa acutangula, Lupinus spp., Luzula sylvatica, Lycopersicon spp. M (e.g. Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme), Macrotyloma spp., Malus spp., Malpighia emarginata, Mammea americana, Mangifera indica, Manihot spp., Manilkara zapota, Medicago sativa, Meliotus spp., Mentha spp., Miscanthus sinensis, Momordica spp., Morus nigra, Musa spp., Nicotiana spp., Olea spp., Opuntia spp., Ornithopus spp., Oryza spp. (e.g. Oryza sativa, Oryza latifolia), Panicum 5 miliaceum, Panicum virgatum, Passiflora edulis, Pastinaca sativa, Pennisetum sp., Persea spp., Petroselinum crispum, Phalaris arundinacea, Phaseolus spp., Phleum pratense, 35 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Phoenix spp., Phragmites australis, Physalis spp., Pinus spp., Pistacia vera, Pisum spp., Poa spp., Populus spp., Prosopis spp., Prunus spp., Psidium spp., Punica granatum, Pyrus communis, Quercus spp., Raphanus sativus, Rheum rhabarbarum, Ribes spp., Ricinus communis, Rubus spp., Saccharum spp., Salix sp., Sambucus spp., Secale cereale, 5 Sesamum spp., Sinapis sp., Solanum spp. (e.g. Solanum tuberosum, Solanum integrifolium or Solanum lycopersicum), Sorghum bicolor, Spinacia spp., Syzygium spp., Tagetes spp., Tamarindus indica, Theobroma cacao, Trifolium spp., Triticosecale rimpaui, Triticum spp. (e.g. Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sativum or Triticum vulgare), Tropaeolum minus, Tropaeolum majus, J Vaccinium spp., Vicia spp., Vigna spp., Viola odorata, Vitis spp., Zea mays, Zizania palustris, Ziziphus spp., amongst others. Detailed description of the invention Surprisingly, it has now been found that modulating expression in a plant of a nucleic acid 5 encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide gives plants having enhanced yield-related traits relative to control plants. According to a first embodiment, the present invention provides a method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant of a nucleic acid encoding a DOF-C2 domain transcription factor polypeptide or a MYB7 polypeptide. The expressions "enhancing/enhance(d) yield-related traits" and "improving/improved yield related traits" have the equivalent meanings and are used inter-exchangably herein. The expressions "improving/improve(d) yield-related traits" and "improving/improve(d) plant 5 growth characteristics" have the equivalent meanings and are used inter-exchangably herein. A preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide is by introducing M0 and expressing in a plant a nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide respectively. Any reference hereinafter to a "protein useful in the methods of the invention" is taken to mean a DOF-C2 domain transcription factor polypeptide or a MYB7 polypeptide as defined 35 herein. Any reference hereinafter to a "nucleic acid useful in the methods of the invention" is 36 6022075_1 (GHMatters) P83714.AU.1 LEOWNR taken to mean a nucleic acid capable of encoding such a DOF-C2 domain transcription factor polypeptide or such a MYB7 polypeptide. The nucleic acid to be introduced into a plant (and therefore useful in performing the methods of the invention) is any nucleic acid encoding the type of protein which will now be described, hereafter also named "DOF-C2 5 transcription factor nucleic acid" or "DOF-C2 transcription factor gene" or "MYB7 nucleic acid" or "MYB7 gene". The term "DOF-C2 transcription factor polypeptide" as defined herein refers to any polypeptide comprising feature (i), and feature (ii) as follow: J (i) A DOF domain having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 96%, 97%, 98%, 99% or more sequence identity to either the DOF domain sequences represented by SEQ ID NO: 35 or SEQ ID NO: 36; and (ii) Motif 1: ERKARPQKDQ (SEQ ID NO: 37) having zero, one or more 5 conservative amino acid substitution(s) and/or having in increasing order of preference five, four, three, two or one non-conservative amino acid substitutition(s); and/or Motif II: YWSGMI (SEQ ID NO: 38) having zero, one or more conservative amino acid subtitutions and/or having in increasing order of preference three, two or one non-conservative amino acid substitutition(s). The terms "DOF-C2 transcription factor polypeptide", "DOF-C2 transcription factor protein", "DOF-C2 transcription factor", "DOF-C2 polypeptide" and "DOF-C2 protein" as used herein have the same meaning and are inter-exchangeable. 5 Additionally, DOF-C2 polypeptides may comprise one, two, three, four or all of the following motifs: - Motif Ill: RLLFPFEDLKPLVS (SEQ ID NO: 39) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of 30 preference five, four, three, two or one non-conservative amino acid substitutition(s); and/or - Motif IV: INVKPMEEI (SEQ ID NO: 40) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference four, three, two or one non-conservative amino acid substitutition(s); and/or; 35 - Motif V: KNPKLLHEGAQDLNLAFPHH (SEQ ID NO: 41) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of 37 6022075_1 (GHMatters) P83714.AU.1 LEOWNR preference nine, eight, seven, six, five, four, three, two or one non-conservative amino acid substitutition(s); and/or - Motif VI: MELLRSTGCYM (SEQ ID NO: 42) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference five, four, 5 three, two or one non-conservative amino acid substitutition(s); and/or - Motif VII: MMDSNSVLYSSLGFPTMPDYK (SEQ ID NO: 43 having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference nine, eight, seven, six, five, four, three, two or one non-conservative amino acid substitutition(s). A preferred polypeptide useful in the methods of the invention comprises a Dof domain as described in feature (i) and comprises both Motif I and II. More preferably, comprises Motif 1, Motif || and Motif Ill. Further preferably the polypeptide comprises also Motif Ill. Further preferably the polypeptide comprises also Motif IV. Most preferably the polypeptide 5 comprises a Dof domain as described in feature (i) and Motif 1, Motif II, Motif Ill, IV and V. SEQ ID NO: 2 (encoded by SEQ ID NO: 1) is an example of a DOF-C2 transcription factor polypeptide comprising features (i) and (ii) as defined hereinabove, i.e. having at least 60% sequence identity to either the Dof domain represented by SEQ ID NO: 35 or SEQ ID NO: J 36; and Motif I and in this case additionally comprising Motif II. Further examples of DOF-C2 transcription factor polypeptides comprising features (i) and (ii) as defined hereinabove are given in Table Al. The term "table A" used in this specification is to be taken to specify the content of table Al 5 and/or A2. The term "table Al" used in this specification is to be taken to specify the content of table Al. The term "table A2" used in this specification is to be taken to specify the content of table A2. In one preferred embodiment, the term "table A" means table Al. In one preferred embodiment, the term "table A" means table A2. The term "table B" used in this specification is to be taken to specify the content of table Bl 30 and/or B2. The term "table Bl" used in this specification is to be taken to specify the content of table Bl. The term "table B2" used in this specification is to be taken to specify the content of table B2. In one preferred embodiment, the term "table B" means table Bl. In one preferred embodiment, the term "table B" means table B2. The term "table C" used in this specification is to be taken to specify the content of table Cl 35 and/or C2. The term "table Cl" used in this specification is to be taken to specify the content of table Cl. The term "table C2" used in this specification is to be taken to specify the 38 6022075_1 (GHMatters) P83714.AU.1 LEOWNR content of table C2. In one preferred embodiment, the term "table C" means table Cl. In one preferred embodiment, the term "table C" means table C2. The term "table D" used in this specification is to be taken to specify the content of table Dl and/or D2. The term "table Dl" used in this specification is to be taken to specify the content 5 of table Dl. The term "table D2" used in this specification is to be taken to specify the content of table D2. In one preferred embodiment, the term "table D" means table Dl. In one preferred embodiment, the term "table D" means table D2. The term "table 2" used in this specification is to be taken to specify the content of table 2A and/or table 2B and/or table 2C. The term "table 2A" used in this specification is to be taken J to specify the content of table 2A. The term "table 2B" used in this specification is to be taken to specify the content of table 2B. The term "table 2C" used in this specification is to be taken to specify the content of table 2C. In one preferred embodiment, the term "table 2" means table 2A. In one preferred embodiment, the term "table 2" means table 2B. In one preferred embodiment, the term "table 2" means table 2C. 5 The polypeptides given in Table Al are examples of "paralogues and orthologues" of a DOF-C2 transcription factor polypeptide represented by SEQ ID NO: 2 from various plant origins belonging to the major orthologous group Cc, subgroup C2 and C2.1 and C2.2 as defined in Figure 2 and Figure 3 of Lijavetzky et al. 2004. Preferred polypeptides useful for J practising the invention belong to the orthologous group C2 (which comprises C2 of arabidopsis and C2.1 and C2.2 of rice) as defined by Lijavetzky et al. 2004. A preferred DOF-C2 polypeptide of the invention is a paralog or an ortholog of any of the polypeptides given in Table Al. 5 Alternatively, the homologue of DOF-C2 transcription factor polypeptide has in increasing order of preference at least 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, M0 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% overall sequence identity to the amino acid represented by SEQ ID NO: 2, and comprises feature (i), and feature (ii) as follows: (i) A DOF domain having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 96%, 97%, 98%, 99% or 35 more sequence identity to either the DOF domains represented by SEQ ID NO: 35 or SEQ ID NO: 36; and 39 6022075_1 (GHMatters) P83714.AU.1 LEOWNR (ii) Motif 1: ERKARPQKDQ (SEQ ID NO: 37) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference five, four, three, two or one non-conservative amino acid substitutition(s); and/or 5 Motif II: YWSGMI (SEQ ID NO: 38) having zero, one or more conservative amino acid subtitutions and/or having in increasing order of preference three, two or one non-conservative amino acid substitutition(s). J A "MYB7 polypeptide" as defined herein refers to any R2R3 MYB polypeptide comprising two SANT domains (SMART entry SM00717, MybDNA-binding domain (Pfam entry PF00249), Homeodomainlike (Superfamily entry SSF46689)), provided that the R2R3 MYB polypeptide is not OsMYB4 encoded by SEQ ID NO: 141 or having the sequence of SEQ ID NO: 142. 5 In addition, a "MYB7 polypeptide" furthermore comprises four or more of Motifs 1 to 7, preferably five or more of Motifs 1 to 7, more preferably six or more of Motifs 1 to 7, most preferably all of Motifs 1 to 7. J Motif 1 (SEQ ID NO: 55): (T/S)X(E/Q/D)EDXXLXX(Y/H)IXXXG; wherein X in position 2 can be any amino acid but preferably one of K, Q, A, P, T, I, S, more preferably K or Q; wherein X in position 6 can be any amino acid but preferably one of Q, E, D, A, S, more preferably Q, E, or D; wherein X in position 7 can be any amino acid but preferably one of R, L, K, M, I, more preferably R, L or K; wherein X in position 9 can be any amino acid but preferably one 5 of 1, V, T, G, L, A, more preferably 1, V, or T; wherein X in position 10 can be any amino acid but preferably one of N, D, A, S, K, G, more preferably N, D, A, or S; wherein X in position 13 can be any amino acid but preferably one of R, K, Q, E, T, N, more preferably R, K, Q or E; wherein X in position 14 can be any amino acid but preferably one of V, K, A, S, T, E, N, more preferably V, K, A or S; and wherein X in position 15 can be any amino acid but 30 preferably one of Y, H, N, D, more preferably H or Y. Motif 2 (SEQ ID NO: 56): (E/Y/P/H/L)(G/S)(C/N/S/R/G)W(R/N)(S/T/A/L/N)(L/I)P(K/R/T/A/S)(A/S/K/N/L/R). Preferably motif 2 is EG(C/N)WR(S/T/A)LP(K/R)(A/S). 35 40 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Motif 3 (SEQ ID NO: 57): RCGKSCRLRWXNYLRP, wherein X can be any amino acid, preferably one of 1, M, L, or T. Motif 4 (SEQ ID NO: 58): RTDNE(IN)KN(Y/H/F)WN. Preferably motif 4 is RTDNEIKNYWN 5 Motif 5 (SEQ ID NO: 59): (T/S)(H/N/R)(I/V/L)(K/R/S)(R/K)(K/R)(L/I)XXXG(I/L/T)(D/T)(P/L), wherein X in position 8 can be any amino acid, preferably one of 1, L, V, T, A, R, more preferably 1, L, V or T; wherein X in position 9 can be any amino acid, preferably one of S, N, R, G, A, V, K, Q, preferably one of S, N, R, G or A; wherein X on position 10 can be any J amino acid, preferably one of R, K, Q, M, T. Preferably motif 5 is TH(I/V/L)(K/R)(R/K)(K/R)(L/I)XXXG(1/L)DP. Motif 6 (SEQ ID NO: 60): X(P/L/Q/W)(D/EN)(L/I)NL(E/D)LX(1/LN)(S/D/N/G)(L/P/I)(P/S/AN/T), wherein X in position 1 5 can be any amino acid, preferably one of F, G, C, L, D or Y and wherein X in position 9 can be any amino acid, preferably one of R, K, G, T, C, D, S. Motif 7 (SEQ ID NO: 61): (F/Y/C/D)(R/S/T)(S/T/G/R)(L/I)(E/P)(M/T)K J Alternatively, the homologue of a MYB7 protein has in increasing order of preference at least 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 5 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% overall sequence identity to the amino acid represented by SEQ ID NO: 50, provided that the homologous protein comprises conserved motifs as outlined above and provided that the homologue is not OsMYB4 as given in SEQ ID NO: 142. 30 The overall sequence identity is determined using a global alignment algorithm, such as the Needleman Wunsch algorithm in the program GAP (GCG Wisconsin Package, Accelrys), preferably with default parameters. Compared to overall sequence identity, the sequence identity will generally be higher when only conserved domains or motifs are considered. 35 Local alignment algorithms, such as BLAST may be used to determine sequence similarity 41 6022075_1 (GHMatters) P83714.AU.1 LEOWNR in a conserved region of polypeptide, such as a DOF domain in a DOF-C2 transcription factor polypeptide. Preferably, the polypeptide sequence which when used in the construction of a phylogenetic 5 tree, such as the one depicted in Figure X, clusters within group C2 which comprises the amino acid sequence represented by SEQ ID NO: 2 rather than with any other group. The term "domain" and "motif" is defined in the "definitions" section herein. Specialist databases exist for the identification of domains, for example, SMART (Schultz et al. (1998) J Proc. NatI. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nucleic Acids Res 30, 242 244), InterPro (Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318), Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., 5 Lathrop R., Searls D., Eds., pp53-61, AAAI Press, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004)), or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002)). A set of tools for in silico analysis of protein sequences is available on the ExPASy proteomics server (Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784 J 3788(2003)). Domains or motifs may also be identified using routine techniques, such as by sequence alignment. Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of 5 Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is 30 publicly available through the National Centre for Biotechnology Information (NCBI). Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package 35 (Campanella et al., BMC Bioinformatics. 2003 Jul 10;4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual 42 6022075_1 (GHMatters) P83714.AU.1 LEOWNR editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains may also be used. The sequence identity values may be determined over the entire nucleic acid or amino acid sequence or 5 over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. For local alignments, the Smith-Waterman algorithm is particularly useful (Smith TF, Waterman MS (1981) J. Mol. Biol 147(1);195-7). Alternatively, a DOF-C2 domain transcription factor polypeptide useful in the methods of the J invention may be identified by performing a sequence comparison with known DOF-C2 domain transcription factor polypeptide and establishing the sequence similarity. The sequences may be aligned using any of the methods well known in the art such as Blast (for local alignment) or BestFit (for global alignment) algorithms. The probability for the alignment to occur with a given sequence is taken as basis for identifying similar polypeptides. A 5 parameter that is typically used to represent such probability is called e-value. The E-value is a measure of the reliability of the S score. The S score is a measure of the similarity of the query to the sequence shown. The e-value describes how often a given S score is expected to occur at random. The e-value cut-off may be as high as 1.0. The typical threshold for a trusted (true) hit showing significant sequence homology to the query sequence and J resulting from a BLAST search is lower than 1.e-5 (e elevated to the 5 th potential), in some instance an even lower threshold is taken, for example l.e-10 (e elevated to the 10 th potential) or even lower. Preferably a DOF-C2 domain transcription factor polypeptide useful in the methods of the 5 invention have in increasing order of preference an e-value lower than l.e-10, 1.e-15, l.e 20, 1.e-25, 1.e-50, 1.e-75, 1.e-100, 1.e-150, 1.e-200, 1.e-300, 1.e-400, and 1.e-500 in an alignment with any of the polypeptides of Table Al. It should be understood that a nucleic acids encoding a DOF-C2 domain transcription factor M0 polypeptide according to the invention it is not restricted to sequences of natural origin. The nucleic acid may encode a "de novo" designed DOF-C2 domain transcription factor polypeptide. Furthermore, DOF-C2 transcription factor polypeptides typically have DNA-binding activity 35 and have a nuclear localization signal and an activation domain. The presence of an activation domain and DNA-binding activity may easily be determined by a person skilled in 43 6022075_1 (GHMatters) P83714.AU.1 LEOWNR the art using routine techniques and procedures. Experimental procedures to measure DNA binding activities of Dof domain polypeptides have been described (Umemura et al. 2004; Yanagisawa, S. and Sheen, J. (1998) Plant Cell 10: 75-89; Plesch, G., Ehrhardt, T. and Mueller-Roeber, B. (2001) Plant J. 28: 455-464). 5 Preferred DOF-C2 transcription factor polypeptides useful in the methods of the invention are able to bind to DNA framents and/or gene promoter regions comprising the sequence (A/T)AAAG (SEQ ID NO : 44) which represents the recognized DNA binding core motif for Dof domains. In addition, DOF-C2 domain transcription factor polypeptides, when expressed in rice according to the methods of the present invention as outlined in Examples 5 and 6, give plants having increased (or enhanced) yield-related traits, in particular the total weight of the seeds, the total number of seeds per plant, the number of filled seeds, the number of flowers 5 per panicle and the harvest index. The present invention is illustrated by transforming plants with the nucleic acid sequence represented by SEQ ID NO: 1, encoding the polypeptide sequence of SEQ ID NO: 2. However, performance of the invention is not restricted to these sequences; the methods of J the invention may advantageously be performed using any DOF-C2 domain transcription factor-encoding nucleic acid or DOF-C2 domain transcription factor polypeptide as defined herein. Furthermore, MYB7 polypeptides (at least in their native form) typically have DNA-binding 5 activity and an activation domain. A person skilled in the art may easily determine the presence of an activation domain and DNA-binding activity using routine techniques and procedures. Proteins interacting with MYB7 polypeptides (for example in transcriptional complexes) may easily be identified using standard techniques for a person skilled in the art, such as two-hybrid interaction. It is postulated that MYB7 proteins interact with BHLH M0 transcription factors (Zimmerman et al., Plant Journal 40, 22-34, 2004). In addition, MYB7 polypeptides, when expressed in rice according to the methods of the present invention as outlined in Examples 8 and 9, give plants having enhanced yield related traits, in particular increased biomass and/or increased emergence vigour. 35 44 6022075_1 (GHMatters) P83714.AU.1 LEOWNR The present invention is illustrated by transforming plants with the nucleic acid sequence represented by SEQ ID NO: 49, encoding the polypeptide sequence of SEQ ID NO: 50. However, performance of the invention is not restricted to these sequences; the methods of the invention may advantageously be performed using any MYB7-encoding nucleic acid or 5 MYB7 polypeptide as defined herein. Examples of nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides are given in Table Al of Example 1 herein. Such nucleic acids are useful in performing the methods of the invention. The amino acid sequences given in Table Al of J Example 1 are example sequences of orthologues and paralogues of the DOF-C2 domain transcription factor polypeptide represented by SEQ ID NO: 2 or of the MYB7 polypeptide represented by SEQ ID NO: 50; the terms "orthologues" and "paralogues" being as defined herein. Further orthologues and paralogues may readily be identified by performing a so called reciprocal blast search. Typically, this involves a first BLAST involving BLASTing a 5 query sequence (for example using any of the sequences listed in Table A of Example 1) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) are generally used when starting from a nucleotide sequence, and BLASTP or TBLASTN (using standard default values) when starting from a protein sequence. The BLAST results may optionally be filtered. The full J length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is in one embodiment SEQ ID NO: 1 or SEQ ID NO: 2 and in another embodiment SEQ ID NO: 49 or SEQ ID NO: 50, the second BLAST would therefore be against Arabidopsis thaliana sequences). The results of the first and second 5 BLASTs are then compared. A paralogue is identified if a high-ranking hit from the first blast is from the same species as from which the query sequence is derived, a BLAST back then ideally results in the query sequence amongst the highest hits; an orthologue is identified if a high-ranking hit in the first BLAST is not from the same species as from which the query sequence is derived, and preferably results upon BLAST back in the query sequence being M0 among the highest hits. High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, 35 comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or 45 6022075_1 (GHMatters) P83714.AU.1 LEOWNR polypeptide) sequences over a particular length. In the case of large families, ClustalW may be used, followed by a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. 5 Nucleic acid variants may also be useful in practising the methods of the invention. Examples of such variants include nucleic acids encoding homologues and derivatives of any one of the amino acid sequences given in Table A of Example 1, the terms "homologue" and "derivative" being as defined herein. Also useful in the methods of the invention are nucleic acids encoding homologues and derivatives of orthologues or paralogues of any one J of the amino acid sequences given in Table A of Example 1. Homologues and derivatives useful in the methods of the present invention have substantially the same biological and functional activity as the unmodified protein from which they are derived. Further nucleic acid variants useful in practising the methods of the invention include 5 portions of nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides, nucleic acids hybridising to nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides, splice variants of nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides, allelic variants of nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides and variants of nucleic acids J encoding DOF-C2 domain transcription factor or MYB7 polypeptides obtained by gene shuffling. The terms hybridising sequence, splice variant, allelic variant and gene shuffling are as described herein. The term "portion" as defined herein refers to a piece of DNA encoding a polypeptide 5 comprising feature (i), and feature (ii) as follow: (i) A DOF domain having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 96%, 97%, 98%, 99% or more sequence identity to either the DOF domain represented by SEQ ID NO: 35 or SEQ ID NO: 36; and 30 (ii) Motif 1: ERKARPQKDQ (SEQ ID NO: 37) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference five, four, three, two or one non-conservative amino acid substitutition(s); and/or Motif II: YWSGMI (SEQ ID NO: 38) having zero, one or more conservative amino acid subtitutions and/or having in increasing order of preference three, two or one 35 non-conservative amino acid substitutition(s). 46 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Additionally the polypeptide in the "portion" above may may comprise any one, two, three, four or all of the following motifs: - Motif Ill: RLLFPFEDLKPLVS (SEQ ID NO: 39) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of 5 preference five, four, three, two or one non-conservative amino acid substitutition(s); and/or - Motif IV: INVKPMEEI (SEQ ID NO: 40) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference four, three, two or one non-conservative amino acid substitutition(s); and/or; J - Motif V: KNPKLLHEGAQDLNLAFPHH (SEQ ID NO: 41) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference nine, eight, seven, six, five, four, three, two or one non-conservative amino acid substitutition(s); and/or - Motif VI: MELLRSTGCYM (SEQ ID NO: 42) having zero, one or more conservative 5 amino acid substitution(s) and/or having in increasing order of preference five, four, three, two or one non-conservative amino acid substitutition(s); and/or - Motif VII: MMDSNSVLYSSLGFPTMPDYK (SEQ ID NO: 43 having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference nine, eight, seven, six, five, four, three, two or one non-conservative J amino acid substitutition(s). Nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides need not be full-length nucleic acids, since performance of the methods of the invention does not rely on the use of full-length nucleic acid sequences. According to the present invention, there is 5 provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a portion of any one of the nucleic acid sequences given in Table A of Example 1, or a portion of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table A of Example 1. 30 A portion of a nucleic acid may be prepared, for example, by making one or more deletions to the nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non-coding) sequences in order to, for example, produce a protein that combines several activities. When fused to other coding sequences, the resultant polypeptide produced upon translation may be bigger than that predicted for the protein portion. 35 47 6022075_1 (GHMatters) P83714.AU.1 LEOWNR In one embodiment, portions useful in the methods of the invention, encode a DOF-C2 domain transcription factor polypeptide as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table Al of Example 1. Preferably, the portion is a portion of any one of the nucleic acids given in Table Al of Example 1, or is 5 a portion of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table Al of Example 1. Preferably the portion is at least 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 1000 or more consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in Table Al of Example 1, or of a nucleic acid encoding an orthologue or paralogue of any one J of the amino acid sequences given in Table Al of Example 1. Most preferably the portion is a portion of the nucleic acid of SEQ ID NO: 1. Preferably, the portion encodes a fragment of an amino acid sequence which, when used in the construction of a phylogenetic tree, such as the one depicted in Figure 3, clusters within group C2 which comprises the amino acid sequence represented by SEQ ID NO: 2 rather than with any other group. 5 In another embodiment, portions useful in the methods of the invention, encode a MYB7 polypeptide as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table A2 of Example 1. Preferably, the portion is a portion of any one of the nucleic acids given in Table A2 of Example 1, or is a portion of a nucleic J acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table A2 of Example 1. Preferably the portion is at least 400, 450, 500, 550, 600, 650, 700, 750, 800 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in Table A2 of Example 1, or of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table A2 of 5 Example 1. Most preferably the portion is a portion of the nucleic acid of SEQ ID NO: 49. Another nucleic acid variant useful in the methods of the invention is a nucleic acid capable of hybridising, under reduced stringency conditions, preferably under stringent conditions, with a nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide 30 as defined herein, or with a portion as defined herein. According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a nucleic acid capable of hybridizing to any one of the nucleic acids given in Table A of Example 1, or comprising 35 introducing and expressing in a plant a nucleic acid capable of hybridising to a nucleic acid 48 6022075_1 (GHMatters) P83714.AU.1 LEOWNR encoding an orthologue, paralogue or homologue of any of the nucleic acid sequences given in Table A of Example 1. Hybridising sequences useful in the methods of the invention encode a DOF-C2 domain 5 transcription factor or a MYB7 polypeptide as defined herein, having substantially the same biological activity as the amino acid sequences given in Table A of Example 1. Preferably, the hybridising sequence is capable of hybridising to any one of the nucleic acids given in Table A of Example 1, or to a portion of any of these sequences, a portion being as defined above, or the hybridising sequence is capable of hybridising to a nucleic acid encoding an J orthologue or paralogue of any one of the amino acid sequences given in Table A of Example 1. Most preferably, the hybridising sequence is capable of hybridising to a nucleic acid as represented by SEQ ID NO: 1, or SEQ ID NO: 49 or to a portion thereof. Preferably, the hybridising sequence encodes a polypeptide with an amino acid sequence 5 which, when full-length and used in the construction of a phylogenetic tree, such as the one depicted in Figure 3, clusters within group C2 which comprises the amino acid sequence represented by SEQ ID NO: 2 rather than with any other group. Another nucleic acid variant useful in the methods of the invention is a splice variant J encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide as defined hereinabove, a splice variant being as defined herein. According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a splice variant of any one 5 of the nucleic acid sequences given in Table A of Example 1, or a splice variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table A of Example 1. In one embodiment, preferred splice variants are splice variants of a nucleic acid 30 represented by SEQ ID NO: 1, or a splice variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 2. Preferably, the amino acid sequence encoded by the splice variant, when used in the construction of a phylogenetic tree, such as the one depicted in Figure 3, clusters within group C2 which comprises the amino acid sequence represented by SEQ ID NO: 2 rather than with any other group. 35 49 6022075_1 (GHMatters) P83714.AU.1 LEOWNR In another embodiment, preferred splice variants are splice variants of a nucleic acid represented by SEQ ID NO: 49, or a splice variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 50. 5 Another nucleic acid variant useful in performing the methods of the invention is an allelic variant of a nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide as defined hereinabove, an allelic variant being as defined herein. According to the present invention, there is provided a method for enhancing yield-related J traits in plants, comprising introducing and expressing in a plant an allelic variant of any one of the nucleic acids given in Table A of Example 1, or comprising introducing and expressing in a plant an allelic variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table A of Example 1. 5 The allelic variants useful in the methods of the present invention have substantially the same biological activity as the DOF-C2 domain transcription factor polypeptide of SEQ ID NO: 2 and any of the amino acids depicted in Table Al of Example 1. Allelic variants exist in nature, and encompassed within the methods of the present invention is the use of these natural alleles. Preferably, the allelic variant is an allelic variant of SEQ ID NO: 1 or an J allelic variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 2. Preferably, the amino acid sequence encoded by the allelic variant, when used in the construction of a phylogenetic tree, such as the one depicted in Figure 3, clusters within group C2 which comprises the amino acid sequence represented by SEQ ID NO: 2 rather than with any other group. 5 In another embodiment, the allelic variants useful in the methods of the present invention have substantially the same biological activity as the MYB7 polypeptide of SEQ ID NO: 50 and any of the amino acids depicted in Table A2 of Example 1. Allelic variants exist in nature, and encompassed within the methods of the present invention is the use of these natural alleles. Preferably, the allelic variant is an allelic variant of SEQ ID NO: 49 or an M0 allelic variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 50. Gene shuffling or directed evolution may also be used to generate variants of nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides as defined above; the term "gene shuffling" being as defined herein. 35 50 6022075_1 (GHMatters) P83714.AU.1 LEOWNR According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a variant of any one of the nucleic acid sequences given in Table A of Example 1, or comprising introducing and expressing in a plant a variant of a nucleic acid encoding an orthologue, paralogue or 5 homologue of any of the amino acid sequences given in Table A of Example 1, which variant nucleic acid is obtained by gene shuffling. Preferably, the amino acid sequence encoded by the variant nucleic acid obtained by gene shuffling, when used in the construction of a phylogenetic tree such as the one depicted in J Figure 3, clusters within group C2 which comprises the amino acid sequence represented by SEQ ID NO: 2 rather than with any other group. Furthermore, nucleic acid variants may also be obtained by site-directed mutagenesis. Several methods are available to achieve site-directed mutagenesis, the most common 5 being PCR based methods (Current Protocols in Molecular Biology. Wiley Eds.). Nucleic acids encoding DOF-C2 domain transcription factor polypeptides may be derived from any natural or artificial source. The nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. J Preferably the DOF-C2 domain transcription factor polypeptide-encoding nucleic acid is from a plant, further preferably from a dicotyledonous plant, more preferably from the family Brasicaceae, most preferably the nucleic acid is from Arabidopsis thaliana. Performance of the methods of the invention gives plants having enhanced yield-related 5 traits. In particular performance of the methods of the invention gives plants having emergence vigour and/or increased yield, especially increased seed yield and/or biomass relative to control plants. The terms "yield", "seed yield" and "emergence vigour" are described in more detail in the "definitions" section herein. 30 Reference herein to enhanced yield-related traits is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground. In particular, such harvestable parts are in one embodiment seeds, and performance of the 35 methods of the invention results in plants having increased seed yield relative to the seed yield of control plants. 51 6022075_1 (GHMatters) P83714.AU.1 LEOWNR In another embodiment, such harvestable parts are vegetative biomass and/or seeds, and performance of the methods of the invention results in plants having increased biomass and/or seed yield relative to control plants. Preferably, the vegetative biomass is above 5 ground biomass. Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants established per square meter, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, J kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per square meter, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle 5 (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. J In one embodiment, the present invention provides a method for increasing yield, especially seed yield of plants, relative to control plants, which method comprises modulating expression in a plant of a nucleic acid encoding a DOF-C2 domain transcription factor polypeptide as defined herein. In another embodiment, the present invention provides a method for increasing yield, 5 especially biomass of plants, relative to control plants, which method comprises modulating expression in a plant of a nucleic acid encoding a MYB7 polypeptide as defined herein. Since the transgenic plants according to the present invention have increased yield, it is likely that these plants exhibit an increased growth rate (during at least part of their life M0 cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle. The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time 35 needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors 52 6022075_1 (GHMatters) P83714.AU.1 LEOWNR such as early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase 5 in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing J period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of corn plants followed by, for example, the sowing and optional harvesting of soybean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an 5 increase in annual biomass production per square meter (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early J season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others. 5 According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate relative to control plants. Therefore, according to the present invention, there is provided a method for increasing the growth rate of plants, which method comprises modulating expression in a plant of a nucleic acid 30 encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide as defined herein. An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of 35 severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the 53 6022075_1 (GHMatters) P83714.AU.1 LEOWNR plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11% or 10% or less in comparison to the control plant under non-stress 5 conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess J water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects. 5 In particular, the methods of the present invention may be performed under non-stress conditions or under conditions of mild drought to give plants having increased yield relative to control plants. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that J adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of "cross talk" between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, 5 resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signalling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of 30 compatible solutes and growth arrest. The term "non-stress" conditions as used herein are those environmental conditions that allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location. Performance of the methods of the invention gives plants grown under non-stress conditions 35 or under mild drought conditions increased yield-related traits relative to control plants grown under comparable conditions. Therefore, according to the present invention, there is 54 6022075_1 (GHMatters) P83714.AU.1 LEOWNR provided a method for increasing yield-related traits in plants grown under non-stress conditions or under mild drought conditions, which method comprises modulating expression in a plant of a nucleic acid encoding a DOF-C2 domain transcription factor or MYB7 polypeptide. 5 Performance of the methods of the invention gives plants grown under conditions of nutrient deficiency, particularly under conditions of nitrogen deficiency, increased yield relative to control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under conditions of J nutrient deficiency, which method comprises modulating expression in a plant of a nucleic acid encoding a DOF-C2 domain transcription factor or MYB7 polypeptide. Nutrient deficiency may result from a lack of nutrients such as nitrogen, phosphates and other phosphorous-containing compounds, potassium, calcium, cadmium, magnesium, manganese, iron and boron, amongst others. 5 The present invention encompasses plants or parts thereof (including seeds) obtainable by the methods according to the present invention. The plants or parts thereof comprise a nucleic acid transgene encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide as defined above. The invention also provides genetic constructs and vectors to facilitate introduction and/or expression in plants of nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of 5 the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention. More specifically, the present invention provides a construct comprising: (a) a nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 30 polypeptide as defined above; (b) one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally (c) a transcription termination sequence. 55 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Preferably, the nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide is as defined above. The term "control sequence" and "termination sequence" are as defined herein. 5 Plants are transformed with a vector comprising any of the nucleic acids described above. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). Advantageously, any type of promoter, whether natural or synthetic, may be used to drive expression of the nucleic acid sequence. A seed-specific or a constitutive promoter is particularly useful in the methods. Preferably the seed-specific promoter is the promoter of a gene encoding a late embryogenesis protein, more preferably is the promoter of the rice 5 WS118 gene. Preferably the constitutive promoter is also a ubiquitous promoter. See the "Definitions" section herein for definitions of the various promoter types. It should be clear that the applicability of the present invention is not restricted to the DOF C2 domain transcription factor or the MYB7 polypeptide-encoding nucleic acid represented 9 by SEQ ID NO: 1 or SEQ ID NO:49, nor is the applicability of the invention restricted to expression of a DOF-C2 domain transcription factor or a MYB7 polypeptide-encoding nucleic acid when driven by a seed-specific promoter, or when driven by a root-specific promoter and/or a constitutive promoter. . 5 The seed specific is preferably a ABA inducible promoter, preferably a WSI 18 promoter from rice. Further preferably the WS118 promoter is represented by a nucleic acid sequence substantially similar to SEQ ID NO: 47. The constitutive promoter is preferably a GOS2 promoter, preferably a GOS2 promoter from M0 rice. Further preferably the constitutive promoter is represented by a nucleic acid sequence substantially similar to SEQ ID NO: 53, most preferably the constitutive promoter is as represented by SEQ ID NO: 53. See Table 2 in the "Definitions" section herein for further examples of seed specific or constitutive promoters. 35 56 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Optionally, one or more terminator sequences may be used in the construct introduced into a plant. Preferably, the construct comprises an expression cassette essentially similar or identical to SEQ ID NO 48, comprising the WS118 promoter, the nucleic acid encoding the DOF-C2 domain transcription factor polypeptide and the T-zein + T-rubisco transcription 5 terminator sequence. In another embodiment, the construct comprises an expression cassette essentially similar or identical to SEQ ID NO 54, comprising the rice GOS2 promoter and the nucleic acid encoding the MYB7 polypeptide. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. An intron sequence may also be added to the 5' untranslated region (UTR) or in the coding sequence to increase the amount of the 5 mature message that accumulates in the cytosol, as described in the definitions section. Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3'UTR and/or 5UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art. J The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the fl-ori and colEl. 5 For the detection of the successful transfer of the nucleic acid sequences as used in the methods of the invention and/or selection of transgenic plants comprising these nucleic acids, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. Selectable markers are M0 described in more detail in the "definitions" section herein. The marker genes may be removed or excised from the transgenic cell once they are no longer needed. Techniques for marker removal are known in the art, useful techniques are described above in the definitions section. 35 The invention also provides a method for the production of transgenic plants having enhanced yield-related traits relative to control plants, comprising introduction and 57 6022075_1 (GHMatters) P83714.AU.1 LEOWNR expression in a plant of any nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide as defined hereinabove. More specifically, the present invention provides a method for the production of transgenic 5 plants having increased enhanced yield-related traits, particularly increased (seed) yield and increased early vigour, which method comprises: (i) introducing and expressing in a plant or plant cell a DOF-C2 domain transcription factor polypeptide-encoding nucleic acid; and (ii) cultivating the plant cell under conditions promoting plant growth and development. In another embodiment, the present invention provides a method for the production of transgenic plants having increased enhanced yield-related traits, particularly increased vegetative biomass and/or increased emergence vigour, which method comprises: 5 (i) introducing and expressing in a plant or plant cell a MYB7 polypeptide-encoding nucleic acid; and (ii) cultivating the plant cell under conditions promoting plant growth and development. The nucleic acid of (i) may be any of the nucleic acids capable of encoding a DOF-C2 J domain transcription factor or a MYB7 polypeptide as defined herein. The nucleic acid may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a preferred feature of the present invention, the nucleic acid is preferably introduced into a plant by 5 transformation. The term "transformation" is described in more detail in the "definitions" section herein. The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications 30 by S.D. Kung and R. Wu, Potrykus or H6fgen and Willmitzer. Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. 35 To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from 58 6022075_1 (GHMatters) P83714.AU.1 LEOWNR untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into 5 plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above. Following DNA transfer and regeneration, putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, J copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art. The generated transformed plants may be propagated by a variety of means, such as by 5 clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal J transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion). The present invention clearly extends to any plant cell or plant produced by any of the 5 methods described herein, and to all plant parts and propagules thereof. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to M0 the invention. The invention also includes host cells containing an isolated nucleic acid encoding a DOF C2 domain transcription factor or a MYB7 polypeptide as defined hereinabove. Preferred host cells according to the invention are plant cells. Host plants for the nucleic acids or the 35 vector used in the method according to the invention, the expression cassette or construct or 59 6022075_1 (GHMatters) P83714.AU.1 LEOWNR vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method. The methods of the invention are advantageously applicable to any plant. Plants that are 5 particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs. According to a preferred embodiment of the present invention, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, cotton, J tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, triticale, sorghum and oats. A preferred rice variety is indica or japonica, or any hybrid of these; a preferred japonica cultivar is Nipponbare . 5 The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, roots, rhizomes, tubers and bulbs. The invention furthermore relates to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins. According to a preferred feature of the invention, the modulated expression is increased expression. Methods for increasing expression of nucleic acids or genes, or gene products, are well documented in the art and examples are provided in the definitions section. 5 As mentioned above, a preferred method for modulating expression of a nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide is by introducing and expressing in a plant a nucleic acid encoding a DOF-C2 domain transcription factor or a MYB7 polypeptide; however the effects of performing the method, i.e. enhancing yield related traits may also be achieved using other well known techniques, including but not 30 limited to T-DNA activation tagging, TILLING, homologous recombination. A description of these techniques is provided in the definitions section. The present invention also encompasses use of nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides as described herein and use of these DOF-C2 35 domain transcription factor or MYB7 polypeptides in enhancing any of the aforementioned yield-related traits in plants. 60 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides described herein, or the DOF-C2 domain transcription factor or a MYB7 polypeptides themselves, may find use in breeding programmes in which a DNA marker is identified which may be 5 genetically linked to a DOF-C2 domain transcription factor or a MYB7 polypeptide-encoding gene. The nucleic acids/genes, or the DOF-C2 domain transcription factor or a MYB7 polypeptides themselves may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having enhanced yield related traits as defined hereinabove in the methods of the invention. Allelic variants of a DOF-C2 domain transcription factor or a MYB7 polypeptide-encoding nucleic acid/gene may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme 5 may start with a collection of allelic variants of so called "natural" origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question. J Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants in which the superior allelic variant was identified with another plant. This could be used, for example, to make a combination of interesting phenotypic features. 5 Nucleic acids encoding DOF-C2 domain transcription factor or MYB7 polypeptides may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of DOF-C2 domain transcription factor or MYB7 polypeptides-encoding nucleic acids requires only a nucleic 30 acid sequence of at least 15 nucleotides in length. The DOF-C2 domain transcription factor or the MYB7 polypeptide-encoding nucleic acids may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the POI-encoding nucleic acids. The resulting banding patterns may 35 then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the 61 6022075_1 (GHMatters) P83714.AU.1 LEOWNR nucleic acids may be used to probe Southern blots containing restriction endonuclease treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the DOF-C2 domain transcription factor or MYB7 polypeptide-encoding nucleic 5 acid in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331). The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous J publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. 5 The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ J hybridisation (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes. 5 A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic 30 Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it 35 may be necessary to identify DNA sequence differences between the parents of the 62 6022075_1 (GHMatters) P83714.AU.1 LEOWNR mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods. The methods according to the present invention result in plants having enhanced yield 5 related traits, as described hereinbefore. These traits may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to other abiotic and biotic stresses, traits modifying various architectural features and/or biochemical and/or physiological features. J In one embodiment the invention relates to subject mater summarized as follows: Item 1. A method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant nucleic acid encoding a DOF-C2 (DNA-binding with one finger, subgroup C2) domain transcription factor polypeptide comprising feature (i) 5 and feature (ii) as follow: (i)a DOF domain having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 96%, 97%, 98%, 99% or more sequence identity to either the DOF domain represented by SEQ ID NO: 83 or SEQ ID NO: 84; and (ii)Motif 1: ERKARPQKDQ (SEQ ID NO: 85) having zero, one or more conservative amino J acid substitution(s) and/or having in increasing order of preference five, four, three, two or one non-conservative amino acid substitutition(s); and/or Motif II: YWSGMI (SEQ ID NO: 86) having zero, one or more conservative amino acid subtitutions and/or having in increasing order of preference three, two or one non conservative amino acid substitutition(s). 5 Item 2. Method according to item 1, wherein said DOF-C2 transcription factor polypeptide furthermore comprises one, two, three, four or all of the following motifs: Motif Ill: RLLFPFEDLKPLVS (SEQ ID NO: 87) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference five, four, three, two or 30 one non-conservative amino acid substitutition(s); and/or Motif IV: INVKPMEEI (SEQ ID NO: 88) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference four, three, two or one non conservative amino acid substitutition(s); and/or; Motif V: KNPKLLHEGAQDLNLAFPHH (SEQ ID NO: 89) having zero, one or more 35 conservative amino acid substitution(s) and/or having in increasing order of preference nine, 63 6022075_1 (GHMatters) P83714.AU.1 LEOWNR eight, seven, six, five, four, three, two or one non-conservative amino acid substitutition(s); and/or Motif VI: MELLRSTGCYM (SEQ ID NO: 90) having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference five, four, three, two or 5 one non-conservative amino acid substitutition(s); and/or Motif VII: MMDSNSVLYSSLGFPTMPDYK (SEQ ID NO: 91 having zero, one or more conservative amino acid substitution(s) and/or having in increasing order of preference nine, eight, seven, six, five, four, three, two or one non-conservative amino acid substitutition(s). J Item 3. Method according to item 1 or 2, wherein said modulated expression is effected by introducing and expressing in a plant a nucleic acid encoding a DOF-C2 transcription factor polypeptide. Item 4. Method according to any preceding item, wherein said nucleic acid encoding a DOF 5 C2 transcription factor polypeptide encodes any one of the proteins listed in Table Al or is a portion of such a nucleic acid, or a nucleic acid capable of hybridising with such a nucleic acid. Item 5. Method according to any preceding item, wherein said nucleic acid sequence J encodes an orthologue or paralogue of any of the proteins given in Table Al. Item 6. Method according to any preceding item, wherein said enhanced yield-related traits comprise increased yield, preferably increased early vigour and/or increased seed yield relative to control plants. 5 Item 7. Method according to any one of items 3 to 6, wherein said nucleic acid is operably linked to a seed-specific promoter, preferably to a promoter of a gene encoding a late embryogenesis protein, most preferably to a WSI18 promoter from rice. 30 Item 8. Method according to any preceding item, wherein said nucleic acid encoding a DOF C2 transcription factor polypeptide is of plant origin, preferably from a dicotyledonous plant, further preferably from the family Brassicaceae, more preferably from the genus Arabidopsis, most preferably from Arabidopsis thaliana. 64 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Item 9. Plant or part thereof, including seeds, obtainable by a method according to any proceeding item, wherein said plant or part thereof comprises a recombinant nucleic acid encoding a DOF-C2 transcription factor polypeptide. 5 Item 10. Construct comprising: (i)nucleic acid encoding a DOF-C2 transcription factor polypeptide as defined in items 1 or 2; (ii)one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally (iii)a transcription termination sequence. Item 11. Construct according to item 10, wherein one of said control sequences is a seed specific promoter, preferably a promoter of a gene encoding a late embryogenesis protein, most preferably a the promoter of the rice WSI 18 gene. 5 Item 12. Use of a construct according to item 10 or 11 in a method for making plants having increased yield, particularly increased early vigour and/or increased seed yield relative to control plants. Item 13. Plant, plant part or plant cell transformed with a construct according to item 10 or J 11. Item 14. Method for the production of a transgenic plant having increased yield, particularly increased early vigour and/or increased seed yield relative to control plants, comprising: (i)introducing and expressing in a plant a nucleic acid encoding a DOF-C2 transcription 5 factor polypeptide as defined in item 1 or 2; and (ii)cultivating the plant cell under conditions promoting plant growth and development. Item 15. Transgenic plant having increased yield, particularly increased early vigour and/or increased seed yield, relative to control plants, resulting from modulated expression of a 30 nucleic acid encoding a DOF-C2 transcription factor polypeptide as defined in item 1 or 2, or a transgenic plant cell derived from said transgenic plant. Item 16. Transgenic plant according to item 9, 13 or 15, or a transgenic plant cell derived thereof, wherein said plant is a crop plant or a monocot or a cereal, such as rice, maize, 35 wheat, barley, millet, rye, triticale, sorghum and oats. 65 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Item 17. Harvestable parts of a plant according to item 16, wherein said harvestable parts are preferably shoot biomass and/or seeds. Item 18. Products derived from a plant according to item 16 and/or from harvestable parts of 5 a plant according to item 17. Item 19. Use of a nucleic acid encoding a DOF-C2 transcription factor polypeptide in increasing plant yield, particularly in increasing seed yield and/or early vigour in plants, relative to control plants. In another embodiment the invention relates to subject mater summarized as follows: Item 20. A method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant of a nucleic acid encoding a MYB7 polypeptide, 5 wherein said MYB7 polypeptide comprises a two SANT domains. Item 21. Method according to item 20, wherein said MYB7 polypeptide comprises four or more of the motifs 1 to 7 (SEQ ID NO: 55 to SEQ ID NO: 61). J Item 22. Method according to item 20 or 21, wherein said modulated expression is effected by introducing and expressing in a plant a nucleic acid encoding a MYB7 polypeptide. Item 23. Method according to the items 20 to 22, wherein said nucleic acid encoding a MYB7 polypeptide encodes any one of the proteins listed in Table A2 or is a portion of such 5 a nucleic acid, or a nucleic acid capable of hybridising with such a nucleic acid. Item 24. Method according to the items 20 to 23, wherein said nucleic acid sequence encodes an orthologue or paralogue of any of the proteins given in Table A2. 30 Item 25. Method according to the items 20 to 24, wherein said enhanced yield-related traits comprise increased increased biomass and/or increased emergence vigour relative to control plants. Item 26. Method according to any one of items 20 to 25, wherein said enhanced yield 35 related traits are obtained under non-stress conditions. 66 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Item 27. Method according to any one of items 22 to 26, wherein said nucleic acid is operably linked to a constitutive promoter, preferably to a GOS2 promoter, most preferably to a GOS2 promoter from rice. 5 Item 28. Method according to the items 20 to 27, wherein said nucleic acid encoding a MYB7 polypeptide is of plant origin, preferably from a dicotyledonous plant, further preferably from the family Brassicaceae, more preferably from the genus Arabidopsis, most preferably from Arabidopsis thaliana. Item 29. Plant or part thereof, including seeds, obtainable by a method according to the items 20 to 28, wherein said plant or part thereof comprises a recombinant nucleic acid encoding a MYB7 polypeptide. 5 Item 30. Construct comprising: (i)nucleic acid encoding a class MYB7 polypeptide as defined in items 20 or 21; (ii)one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally (iii)a transcription termination sequence. Item 31. Construct according to item 30, wherein one of said control sequences is a constitutive promoter, preferably a GOS2 promoter, most preferably a GOS2 promoter from rice. 5 Item 32. Use of a construct according to item 30 or 31 in a method for making plants having increased yield, particularly increased biomass and/or increased emergence vigour relative to control plants. Item 33. Plant, plant part or plant cell transformed with a construct according to item 30 or 30 31. Item 34. Method for the production of a transgenic plant having increased yield, particularly increased biomass and/or increased emergence vigour relative to control plants, comprising: (i)introducing and expressing in a plant a nucleic acid encoding a MYB7 polypeptide as 35 defined in item 20 or 21; and 67 6022075_1 (GHMatters) P83714.AU.1 LEOWNR (ii)cultivating the plant cell under conditions promoting plant growth and development. Item 35. Transgenic plant having increased yield, particularly increased biomass and/or increased emergence vigour, relative to control plants, resulting from modulated expression 5 of a nucleic acid encoding a MYB7 polypeptide as defined in item 20 or 21, or a transgenic plant cell derived from said transgenic plant. Item 36. Transgenic plant according to item 29, 33 or 35, or a transgenic plant cell derived thereof, wherein said plant is a crop plant or a monocot or a cereal, such as rice, maize, J wheat, barley, millet, rye, triticale, sorghum and oats. Item 37. Harvestable parts of a plant according to item 36, wherein said harvestable parts are preferably vegetative biomass. 5 Item 38. Products derived from a plant according to item 36 and/or from harvestable parts of a plant according to item 37. Item 39. Use of a nucleic acid encoding a MYB7 polypeptide in enhancing yield-related traits, particularly in increasing biomass and/or emergence vigour in plants, relative to J control plants. Description of figures The present invention will now be described with reference to the following figures in which: 5 Fig. 1 represents the sequence and domain structure SEQ ID NO: 2. The sequence of the Dof domain is shown in bold characters. Motif I to Motif V are indicated. Fig. 2A represents a multiple alignment of the DOF-C2 transcription factor polypeptides given in table Al. 30 Fig. 2B represents a multiple alignment amino acid sequences alignment of Dof domains present in DOF-C2 transcription factor polypeptides given in table Al. Fig. 3 shows a phylogenetic tree of Arabidopsis and Rice DOF-C2 transcription factor 35 polypeptides. The cluster comprising the subgroup C2 is indicated. 68 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Fig. 4 represents the binary vector for increased expression in Oryza sativa of a SEQ ID NO: 1 under the control of a rice WSI 18 promoter (pWSI 18) 5 Fig. 5 details examples of sequences useful in performing the methods according to the present invention. Fig. 6 represents SEQ ID NO: 50 with the two SANT domains shown in bold and the conserved motifs 1 to 7 underlined. Fig. 7 represents a multiple alignment of various MYB7 proteins Fig. 8 represents the binary vector for increased expression in Oryza sativa of a MYB7 encoding nucleic acid under the control of a rice GOS2 promoter (pGOS2) 5 Fig. 9 details examples of sequences useful in performing the methods according to the present invention. Examples J The present invention will now be described with reference to the following examples, which are by way of illustration alone. The following examples are not intended to completely define or otherwise limit the scope of the invention. DNA manipulation: unless otherwise stated, recombinant DNA techniques are performed 5 according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R.D.D. Croy, published by BIOS Scientific Publications 30 Ltd (UK) and Blackwell Scientific Publications (UK). Example 1: Identification of sequences related to the nucleic acid sequence used in the methods of the invention Sequences (full length cDNA, ESTs or genomic) related to the nucleic acid sequence used 35 in the methods of the present invention were identified amongst those maintained in the 69 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). The program is used to find regions of local similarity between 5 sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. For example, the polypeptide encoded by the nucleic acid used in the present invention was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score J (E-value), where the score reflect the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some instances, the default parameters 5 may be adjusted to modify the stringency of the search. For example the E-value may be increased to show less stringent matches. This way, short nearly exact matches may be identified. Table Al and Table A2 provide a list of nucleic acid sequences related to the nucleic acid D sequence used in the methods of the present invention. Table Al: Examples of DOF-C2 domain transcription factor nucleic acids and polypeptides: Name Orga Nucleic acid SEQ Amino acid SEQ ID nism ID NO: NO: ArathDOFC2_1 Arabidopsis thaliana SEQ ID NO: 1 SEQ ID NO: 2 ArathDOFC2_2 Arabidopsis thaliana SEQ ID NO: 3 SEQ ID NO: 4 ArathDOFC2_3 Arabidopsis thaliana SEQ ID NO: 5 SEQ ID NO: 6 ArathDOFC2_4 Arabidopsis thaliana SEQ ID NO: 7 SEQ ID NO: 8 ArathDOFC2_5 Arabidopsis thaliana SEQ ID NO: 9 SEQ ID NO: 10 ArathDOFC2_6 Arabidopsis thaliana SEQ ID NO: 11 SEQ ID NO: 12 GlymaDOFC2_1 Glycine max SEQ ID NO: 13 SEQ ID NO: 14 GlymaDOFC2_2 Glycine max SEQ ID NO: 15 SEQ ID NO: 16 GlymaDOFC2_3 Glycine max SEQ ID NO: 17 SEQ ID NO: 18 PissaDOFC2_1 Pisum sativum SEQ ID NO: 19 SEQ ID NO: 20 VitviDOFC2_1 Vitis vinifera SEQ ID NO: 21 SEQ ID NO: 22 70 6022075_1 (GHMatters) P83714.AU.1 LEOWNR VitviDOFC2_2 Vitis vinifera SEQ ID NO: 23 SEQ ID NO: 24 NictaDOFC2_1 Nicotiana tabacum SEQ ID NO: 25 SEQ ID NO: 26 HorvuDOFC2_1 Hordeum vulgare SEQ ID NO: 27 SEQ ID NO: 28 OrysaDOFC2_1 Oryza sativa SEQ ID NO: 29 SEQ ID NO: 30 OrysaDOFC2_2 Oryza sativa SEQ ID NO: 31 SEQ ID NO: 32 OrysaDOFC2_3 Oryza sativa SEQ ID NO: 33 SEQ ID NO: 34 Zea mays SEQ ID NO:185 SEQ ID NO:186 Table A2: Examples of MYB7 polypeptides: Plant Source Nucleic acid Protein SEQIDNO: SEQIDNO: Arabidopsis thaliana 49 50 Gossypium hirsutum 62 63 Vitis vinifera 64 65 Solenostemon scutellarioides 66 67 Solanum lycopersicum 68 69 Humulus lupulus 70 71 Populus tremula x Populus tremuloides 72 73 Glycine max 74 75 Brassica rapa subsp. Chinensis 76 77 Brassica rapa var. purpuraria 78 79 Eucalyptus gunnii 80 81 Zea mays 82 83 Dendrobium sp. 84 85 Triticum aestivum 86 87 Hordeum vulgare 88 89 Tradescantia fluminensis 90 91 Picea glauca 92 93 Pinus taeda 94 95 Gossypium raimondii 96 97 Gossypioides kirkii 98 99 Sorghum bicolor 100 101 Gossypium herbaceum 102 103 Physcomitrella patens 104 105 71 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Malus x domestica 106 107 Picea mariana 108 109 Fragaria x ananassa 110 111 Petunia x hybrida 112 113 Lotus japonicus 114 115 Populus x canescens 116 117 Daucus carota 118 119 Fagopyrum cymosum 120 121 Boea crassifolia 122 123 Medicago truncatula 124 125 Arabidopsis thaliana 126 127 Arabidopsis thaliana 128 129 Arabidopsis thaliana 130 131 Oryza sativa 132 133 Oryza sativa 134 135 Oryza sativa 136 137 Oryza sativa 138 139 Antirrhinum majus 140 B. napus 143 144 B. napus 145 146 B. napus 147 148 G. max 149 150 S. lycopersicum 151 152 T. aestivum 153 154 T. aestivum 155 156 T. aestivum 157 158 T. aestivum 159 160 T. aestivum 161 162 P. patens 163 164 P. trichocarpa 165 166 P. trichocarpa 167 168 M. truncatula 169 170 Z. mays 171 172 Z. mays 173 174 72 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Z. mays 175 176 Z. mays 177 178 Z. mays 179 180 Z. mays 181 182 Z. mays 183 184 In some instances, related sequences have tentatively been assembled and publicly disclosed by research institutions, such as The Institute for Genomic Research (TIGR). The Eukaryotic Gene Orthologs (EGO) database may be used to identify such related 5 sequences, either by keyword search or by using the BLAST algorithm with the nucleic acid or polypeptide sequence of interest. SEQ ID NO: 1 and SEQ ID NO: 11 represent two spliced variants at the locus AT4G24060 of the Arabidopsis thaliana genome. Example 2: Alignment of DOF-C2 domain transcription factor polypeptide sequences and MYB7 polypeptide sequences Alignment of polypeptide sequences was performed using the AlignX programme from the Vector NTI (Invitrogen) which is based on the popular Clustal W algorithm of progressive 5 alignment (Thompson et al. (1997) Nucleic Acids Res 25:4876-4882; Chenna et al. (2003). Nucleic Acids Res 31:3497-3500). Default values are for the gap open penalty of 10, for the gap extension penalty of 0,1 and the selected weight matrix is Blosum 62 (if polypeptides are aligned). 0 Concerning the DOF-C2 domain transcription factor polypeptides, minor manual editing may be done to further optimise the alignment. Sequence conservation among DOF-C2 domain transcription factor polypeptides is essentially in the Dof domain of the polypeptides and at the location of the conserved Motifs I to VII as represented by the consensus SEQ ID NO: 37 to 43 (see Figure 2A). The DOF-C2 domain transcription factor polypeptides are aligned 5 in Figure 2A. Figure 2B represents a multiple alignment of the DOF domains as found in the polypeptides of Table Al. A consensus sequence is indicated. Highly conserved amino acid residues amongst the Dof domain transcription factor polypeptides are indicated in the consensus sequence. 73 6022075_1 (GHMatters) P83714.AU.1 LEOWNR A phylogenetic tree of transcription factors from the DOF family of Arabidopsis (At) and rice (Os) is shown in Figure 3. The clade containing the DOF polypeptides of subgroup Cc is indicated by a box. Figure 3 was constructed using a neighbour-joining clustering algorithm as provided in the AlignX programme from the Vector NTI (Invitrogen). 5 Concerning the MYB7 polypeptides, minor manual editing was done to further optimise the alignment. Sequence conservation among MYB7 polypeptides is essentially in the SANT domains in the N-terminal half of the polypeptides, the C-terminal half usually being more variable in sequence length and composition. The MYB7 polypeptides are aligned in Figure J 7. Example 3: Calculation of global percentage identity between polypeptide sequences useful in performing the methods of the invention 5 Global percentages of similarity and identity between full length polypeptide sequences useful in performing the methods of the invention were determined using one of the methods available in the art, the MatGAT (Matrix Global Alignment Tool) software (BMC Bioinformatics. 2003 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. Campanella JJ, Bitincka L, Smalley J; software hosted by J Ledion Bitincka). MatGAT software generates similarity/identity matrices for DNA or protein sequences without needing pre-alignment of the data. The program performs a series of pair-wise alignments using the Myers and Miller global alignment algorithm (with a gap opening penalty of 12, and a gap extension penalty of 2), calculates similarity and identity using for example Blosum 62 (for polypeptides), and then places the results in a distance 5 matrix. Sequence similarity is shown in the bottom half of the dividing line and sequence identity is shown in the top half of the diagonal dividing line. Parameters used in the comparison were: Scoring matrix: Blosum62 30 First Gap: 12 Extending gap: 2 Concerning the DOF-C2 domain transcription factor polypeptides: Results of the software analysis are shown in Table 1 for the global similarity and identity over the full length of the 74 6022075_1 (GHMatters) P83714.AU.1 LEOWNR polypeptide sequences. Percentage identity is given above the diagonal and percentage similarity is given below the diagonal (normal face). Table B1: MatGAT results for global similarity and identity over the full length of the 5 polypeptide sequences. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 1. Arath 45.7 35.0 35.8 27.5 90.6 41.0 42.2 33.5 37.6 45.3 41.6 41.5 29.3 35.4 23.9 DOFC2_1 2. Arath 54.5 35.9 32.3 29.3 45.4 35.2 37.3 27.5 34.9 41.1 38.1 38.2 28.2 33.6 25.4 DOFC2_2 3. Arath 50.4 49.1 54.7 31.3 36.3 37.1 37.4 24.8 32.8 36.2 34.8 35.5 28.5 33.8 24.8 DOFC2_3 4. Arath 51.6 43.5 63.1 35.2 36.0 36.8 35.9 28.6 40.2 40.4 37.8 36.9 26.1 34.0 24.2 DOFC2_4 5. Arath 43.2 43.8 43.9 52.0 30.0 31.5 32.9 25.0 31.8 35.4 31.1 31.4 22.7 27.7 22.8 DOFC2_5 6. Arath 90.6 56.5 51.2 48.0 41.8 41.4 43.1 30.4 36.2 43.3 39.9 40.4 30.3 36.8 23.2 DOFC2_6 7. Glyma 58.4 50.6 50.7 55.6 46.4 55.6 89.7 27.2 41.5 59.6 45.0 49.0 30.4 37.6 26.8 DOFC2_1 8. Glyma 59.4 49.4 50.7 54.5 48.1 57.6 91.8 27.8 42.8 61.2 46.5 50.2 30.8 37.9 25.5 DOFC2_2 9. Glyma 40.0 34.4 32.2 36.3 33.3 36.0 35.3 36.0 33.6 32.9 42.0 33.8 19.3 23.4 19.8 DOFC2_3 9. Pisa 51.0 45.7 44.2 54.1 47.6 48.2 55.2 56.9 45.8 48.6 47.7 44.2 27.1 31.2 23.6 DOFC2_2 11. Vitvi 54.2 51.7 49.6 58.9 51.7 54.1 69.0 73.1 44.1 66.3 54.7 60.8 31.0 38.0 23.1 DOFC2_1 12. Vitvi 48.1 46.0 44.4 50.7 41.2 45.9 52.9 54.2 51.0 60.6 62.1 45.7 26.1 32.1 22.8 DOFC2_2 13. Nicta 54.8 49.4 50.1 51.4 47.3 52.0 63.1 66.7 43.9 63.0 75.2 55.7 30.8 35.5 25.1 DOFC2_1 14. Horvu 37.3 37.9 38.1 34.5 33.3 40.3 38.1 37.7 22.5 34.1 38.1 32.0 38.3 58.3 22.1 DOFC2_1 15. Orysa 45.3 48.0 48.3 46.1 40.3 48.8 50.1 48.3 29.9 40.3 48.5 38.7 46.9 63.3 27.0 DOFC2_1 16. Orysa 37.6 42.6 42.5 40.1 34.0 38.4 36.5 35.1 28.1 33.4 35.1 30.9 35.9 31.1 38.9 DOFC2_2 17. Orysa 49.7 49.5 49.5 43.4 39.2 52.9 50.8 48.9 28.8 43.1 49.7 40.2 47.6 56.8 71.4 37.0 DOFC2_3 75 6022075_1 (GHMatters) P83714.AU.1 LEOWNR The percentage identity between the DOF-C2 domain transcription factor polypeptide sequences useful in performing the methods of the invention can be as low as 27.5 % amino acid identity compared to SEQ ID NO: 2 (indicated in bold in Table 1). The percentage identity with the closest paralogous polypeptide to SEQ ID NO:2 is 45.7 %. The identity of 5 SEQ ID NO:2 to a the spliced variant ArathDOFC2_6 is 90. %. Identity between orthologous the DOF_C2 polypeptides in Table 1 which are form a dicotyledoneous plant origin is in the range of 25-45%. Identity between SEQ ID NO:2 and the orthologous DOFC2 polypeptides shown in Table 1 which are form a monocotyledoneous plant origin is in the range of 23.9-35.4. Concerning the MYB7 polypeptides: Results of the software analysis are shown in Table B2 for the global similarity and identity over the full length of the polypeptide sequences. Percentage identity is given below the diagonal in bold and percentage similarity is given above the diagonal (normal face). 5 The percentage identity between the MYB7 polypeptide sequences useful in performing the methods of the invention can be as low as 28.7% sequence identity compared to SEQ ID NO: 50. 76 6022075_1 (GHMatters) P83714.AU.1 LEOWNR D M D (D M~ 00 L)O~ M~ M~ M-- C-4 CN LO CVD _-) m L6 C 6 (6L ; oL) co -;I (0~ D CO LO) CO cn) (D (D (D N- c) (D C: cu C-L)0. CD Z D i CL6 N-- C6 CO) MC o 0- C4 U, -*- - a)* * C 70 0) ( D CD CD CD -;I L)O~ m CD cr) -;- L C: Lr 0 (1 OC4 LO 0M -r 'l C'? 0J 0J CD -) C ? Z)J Coc-D D -l r q C M crOCO c) LO 0)D~ O~t~ t C)~ n U) 0~ 0 Sw U, U, I Ho MU (~ D - - 00 LO 00 C i~r -uc - (: r--: L6J ~~6 r- c)LO I- I H m (i - c c D m~ m~ r C- C14 C14 U, a) - c Ln U O 00 00 00 04 0 LO) '-I - CO cc 00 ) L o 0. L6 L6 o -j c -j c o C6o; -: o iu (0 -;- LO L LO co c) cD cD cD C~j C-1 Ulf (.0 U, 0 0 1~ U, CDD - = 0 it V- 0- m- o c i C0 C4 U) a). 0 ;1 Lf) Lf) Lf CO LO) Ulf C14 ce) LO 4-- 0D 0J 0- C14 o1 LO c ON ( D r *-- C' 7 y cl 00 C) C) r -- ' 1O _r < - - D ml 00 C I%- C-' a) 00 or) C -~ < CD CD CD -; LO) LO~ LO~ C4 LO 4- L) ~z- . o L) 00 rJ~O oC -- : Ci Lfq "~ Ci "~ Ci (0 D 0 LO -0 MCC 4- a--C < <0 04 CNN- Cr) Co- ( It If (N I C N- 1- L L f cj- C) a) (4N . 00 IfO LO V. a (1) C: CO CN LfLO ~ o C > 0 m co 0) F)~- < m U, o~ - (N4 0 r- N O'OLCVC C N 0 N (0 r L) 0 0- Co a N- - D C- - CZ) .LO LO ~( C-1 LO~ LO cu 0 - < > N ) M- C) L OC C 4 M L O - 0 0 t I~ - ( 0 t 0 0 t c o c 4-C) ( D CD CD; Lf : C6 0 f6 C=; 14 Lf: Lf cu 1-- 0N 00_ Lf 0 C CO <N CO0 N0 f c4)- - C1 - 0 - cu MC c N 6 c Ci 6 'V r-_ If4 IC6 COr) If, (0 0 ( C 0 Z CD Ul O~t C-1 Ul Ul

H)

0 CN- vv< 0- CU < 0r o 0 r- U r o U) cc c . ) - _ o Z Co c*- m -* ) - W le CO C-1 00 1 LO r' O <- a4 aa). n1 - I ~ I- CDt V -~ V) V) cf 1 L 01L 4 C(Ni cc 4= V. cc "~ U') cc I- V cc 4= 4= V.- V) e~ LO cw- r CW) CW) C1 cc LO cc% I~ qq LO cc C-1 cc cc LO LO C'. cc (0 r-- C'. r- r- C'. Lo r- r- C-4 ci r- ) . r-- C'. CW, LO r [- LO LO C14It qq qq LO C-1 cc LO LO C-1 LO CW)rl 0 4 4 csj ce) V) C-') C1 - C'. m , Lo - C4J C4J .4 Uc CJi C4 CJ CW) LO CW) CW) CW) C)C- C14 C-1 LO C-1 C-1 C-1 C14 C-1 e a? CR a? a? Ci " Ci Ci It LC? U, Nt CJ a? C*O -t C' O l C-1 C-1 C14 C14 C%4 C-1 C%4 C-1 C%4 C14 C14 C-1 C-1 C14 C14 C-1 C14 C14 C14 C'. CR OR C4 UI a? OR OR -: OR CR a? C*O ", r*QC p p " -4 UiC= C=; U, U, C4J a) i cc U4 ci U,) U,4 ci , U co U, C-1 C-1 U, C1 U, U, U, le U, le U, C-1 U, U, I~ U, C-1 U, I~ C14 UO V.- 1 l rl- rl- C V)i 00 cc (0 CDI I- C14c)It . C-1 C-1 U, C-1 U, U, 04% le le U, C-1 cc U, U, U, I* (0R C IR( -: C% ? U, cl cl "~% (0 - r-. cl cl r-. cl CO cl 'I * Co C14 .0 C'!I r- (0P cl r--. C- C4 .% a? U,? a? U,? r-4 ( r--. (0 (0; ce - *e C= C= *Y *= CWJ C.. cc V. le a CJ cc C1 * CW) C CW C4J CW) C) C4J C) CW) C4J CW) C4J C) C) C4 Cl C) U, ) U, U, 4 U, , LC U,? -: Ut U,? U, C% CR U,? eO U,4 a) CWI U' %I U, a) V.- .* IR L L) C) U,) 'R I- I- CYI CD U,? r-. U,? -t CR -t -t (0 -t -t a? U,4 U, *lL C?- r--. - (0 I~ O~ a C4 le rl- a )l le 04 CZ) V0 V) C cc I- U, I- C14 C-1 C-1 U, C-1 U, CO U, C%4 le le l C-1 U, (Z0 U, C-1 U, C-1 U, Ut IRt U, V.- le rl- a)a e l 4cc )V ) I - LO I - (4 C-1 C-1 U, C-1 U, O U, L C4 le le l C-1 U, (Z0 U, C-1 U, C-1 U, r-- C-r.~ .0 Lo C4 o Lc c C( W ~ - Gi r-4 r U COi (0 (0; C=; C'.) C-4 U, (4 CO C )V ~ CO CO C= QY) U, CF (00 (oNt , - c L)0 0 c~ .* < -, j M coL eC LO LO a) co a) a) . C- M- M- C- -:I LO C-) LO cc~O cc (0 (LO cc cc' 'LO (0r- ( 6o (0 o6) * )C ...... $- ...... -- -- -- - ------- ------ ............ cc U) U) M ~ . D -1 - 0 - 00 r--: (0 (0 Lo -- ;I M 00I 00c~ r~ V- "- C-' V. CO' Co Cr) C) 00 m- -;I- '0 O m0 m~ ' D C- C-1 C-1) C-1 C-1 C-1) C-1 ,I I0 I0 COC-4 I-C%! c C O r. C-1 C- co r- r-J Co mf L-4 -;j - cr-i cf) Lf) ra m ;I- -;I- f O LO m O LO (0 LfD m~ Lq tp C 0 U, Nt cCi Lf) co C ~' 'go 'go I-~ C-1) I-~ m Co Lf) Lf) - r- ~CV) r- 'LO LO LO r ,-I LO) LO) D ,;I LO) LO) D 'LO cr) C14 Ut V.0 4= V.- LO LO ';-Cc* LO, r-o '* 00 LO) r- 04~ *~ co CNL? ? CRC1 I- O m- 00 D 0)Cj (D ( C-, ........ ------- - ------ .... Cc Co 0) mD C (0(0) 4= C a) - 4 CO M ML cR(C -* I~ LO I~ I~ LO LOO I~ < 00N CD Co v 1 c*-C (D (0 (D 'Co (0 (0 ~c' 4= V- -D a)M " C l 9-,LO ,*-~o C - Co __(qC C-1 U, 1) C-1 001 C-)r i c - z- r o c4 m c) cz* :00 M0D0D L D D C-1) 00~ I- a)~CJ % 0 U' Vo (-6 L6 C)~ L C (0 (D (0 .(D (D -;I (D0 D-D 00 ....... ...... ---- -- -- - . ) 0 L ( ~ o~~- -( ------ ...... U,4 *~o 'I CN 'It CR CO 00 CN O00 0000r 6 ~ ~ ~ ~ ~ ~ c U'O CO )V-V- Oc) .C WO OZt c LO O ai L6 ci c- o6 c, C ------ I----- ---------------- -----3----- -----I---- ---------- ---------------------------------------- --------------------------------- r--------- M~ 04 00 -4 -:I (D C-4 rN- (Dc -- - mC -N- CV) mC - m C,4 6 co - -0 -- c6 r ) mi U) c6 c- o6 CJ - -4 r o r- - :- -- co r- c co UO UO UO r- CV tZ uO S- - 04 M 4 CO -; -'--- 'O (D -I -;- --- ;I - ;- -I -;- -I r n ;-C4C1 S co c- iO co r- Lq O Lq -:C 0 Lq CR iPa M D-I- -o rc o;1 00 -1 a- r- m LO cO - cc LN )-L CO -N C - n L U L -- 0 L~ COU - 4LO LO 0 cc " I* to cc m4 LO LO -c m~ F.O ci LO -;I LO N- ) -;a -;I I~ 4 LO -Rt -ot c 0- .;o 1- - 00 -) - M U) LO Cto cc cc m E) LO LO -I -;I- LO LO LO LO m - U) IW) C-1) U- - CO 04 -0 - - --- '- 0I- L U) nCO !t C-t L- L L*- L L) ) L cn ~ ~ ~ R cCfl -;- -I ;IU;- ) -; U) C) C14 C14 S, C-1 C%4 C% % L- 4 S L0 L' LI eC I 7IC - c lC y C, CIR ?a C L .1 c D LO - - M - - V) O V c cO E) 00 cc cc o e 0 (D U) U ) cr c) ) U) ;1 V- ) 00) cE) r- LE? '0 1- LC cE L6 r_ i L - 4- ----- ---- -- --------- " O c 0 (D (D LO - -I- r- (Dc C14 -- e 1-e CZu ) C-1) CZ) -a O - C U1 C14 -N- -LO N- 4 U) I- CD 00 N cc I- to W OS) " VE) V) ,,I U) U)- - U) -I - -U) U) UZ) C14 0)t CE L ) ~ CE) CZ CZ e) r- -0 O -- ;I) - n C14 00 1-- -- e Lc C-4 I- mE 1- 00 to SL - -4 c c U) o - L e cU) cCO C-4 to Ct4 p-4 CO Cr CO to C4 -4 ~- - ------- ----- ----- - ~ - - - ------- ------ ---- N- - - - ---- N -- ------ ------ C -- LO m Rn C- Lcc I* 4 cE4 cZ C% N .0 C0 Z) r- cc - C-) cc cc cc r- -e -e I* r1) cc I- LO u C1r - e e- ccc U ~ N- ~ c-N- e nt E to-C 4.............. ..4 ...... ....... .. ...... ....... ........... ..... ............... ........ .......... ......... ....... .. ..... ......... 4. 04 - -C CC! CO c c a04 C.0 -to - o O M -O -t CW) a) Cc (D ~ U - 04 (D -* = .) 5 C-4o -o to - -o r 4 r cc; -N 4E cc; )- N- LO CN- CO - C) -to (N W W C4 Cto LO Cto to C- C --- 4--+-4----+- .---- - -4 ..------ -- 4- -4 -Rte V.r .) C0 V * M ce co cce ) C4c) c R , = N- I- -o cc c CO SN -o rr q ) co co o= m LO C0 r -CO qt pq ce C.- I- - V)M ) CD) Cc) (N) (N4 N1 a) CE ) RE) CE D N CO N -C) -(N C=) rN ;o t o Co U) t .. I'l-- ..- O- C) < < 'to L -,L - - L - ------ L L..... ...... ... ... L..........-..... ....- l L --11 l --J..........

r-- co Lo a) C-- -c I* -, 4-i -4 -4- - 4-4 LO C' CCO CCO ccLO cc LO

--------------------

coc e4 V- CO C- -M Co CO to ) 4r sC%4 () 04 04 Vto C/) U, r-I 04(r ;- 4 o- 0) 0-0 C-1) C-1) KW) CWo r-) C.-O -C - -C C R I~~ L...L..L to~ ~~~~~~~~ C- ~ -o -o ~ ~ U r o U U - ' ------- '-------~ co . . ccco:r- r- c r-c - - - - - - ---------- -- - '- si CR LC LC LC O C, 1c 1* ............ - - - - --------- D Kf ~ - 4-4- 4 4 U' V . C ) 'C) ' -;I ' U;I 'O04 M C - U) C;I- LO LO r-0 -) ') U CO -;I NO -COD L L C-') -- (N 'cc '~O C') I~ SO Ito I- I- C4 00 CO? 'D mO mC C' t o '-1 'U, ~t I ~ m U I ~ I -. -r- *'*mLo r-s i csr -;I C') Lo (D (D ) -- ' - I-4 5U) CDo - ~ 'U - - --- -- -- -- -- -- ------- -C' Uo to Cy -r 'It - ' LO r N r o ~ '- N- M -;I r- C-4 (N M( CI- Cc Cc M( C( 4 - 'C= 0. O NLO CD ~ 54 54 0 4 C4 C-4 C4 C4 4-4 4NC) a r: 0' c o 4t Ir- Let L LO - I- c co e C ~ ~ ~ ~ ~ ~ ~ c U2q a)0 o S' U ~' o ~ - ( - 6 - - - ' -to - -c -M - U) D D D eD (D -;I UO C) O Cc cc t SO Ct U6 Mo > o CT- 0 +- --- 4-1 S 'to 0-0 CU LIoC U) G -c 'C 0 tor_ ~ r_ c f C; . i. -UO LO -LO -* c* C - -CO 0 -I (D - - - - 00 I*- S) Cy! C1

-*

C'.) ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ C 'U) 'CD C- cc; r_ i 4) V) 0 04 - co ;j r- co r- -- -- -- --------fC O- ------ ---- - N V0 - r 2 0N- 0 cw) w) c) c) C C-4 C.,) C., C., C, -D U) 'CO: m r-~~~~~( SO (D UO to -r ' - CDC ~'O S) C=)o r r -C' ~ C') 5(N 5 r'It to C'O .I.- o N e C C') C') C') U') cc ' cc ' cc' C') U) C6 U) c,5 ( - - ------ 0to Irt cc I~ C. r*- r*- C') 00) CV m O C') 4 -' cc' '-') ai '- (0N0 00 'n sCz*i 00 C-1 CW C-) C1) -1) C-1 C-) C1)-O D LO CD D -lc:j- LOD -D w e V.- cc U' V)-tU) It U' ) L - r - - 04 ci a C. c CD " j c q sC') ., C') coo --e cc t~( ( r - cq m( I'- CO 0) 1*- C(4 a0) C(N-4 sr m 4= 4=s)sc CU, 5 (O C=) LO C4 LCr 'R-) -0 sco Lr -- CZ) Uo ~cm Sc <) cc < < m c<c O~cS c LVL- LO - - -o -- 4 a L a) cn cr) - 6 co c- - cc M r- oco -::1: L6 C-) -C- ";1- D co ei Li - L C L L - c cc L- Cc 0U c r- ? cO> CN Uc ~ ~ )~ 0 ) -U)L - CN - CE) LU) C L CC- L-CNC C Mr ao r- - -;I M cr '-; co - D LO 04 M - - '-;I 0 -04 0 cD cc m) -;I- -cD r- -;I -;I r- - -D r- a) Dc (Dc O) 00 -;1- r - a) U) -4 - r- oC Icc Icc C 1U) 1) 1J L ZU) LCo C C c c- > c 1 - - 1cc co) - I c - -o -o N- cc Lc -c -6 - -- - C> - - - - U 0 U- -D - - -; U) a) co -- L- rc -;- C ;I CO -;I - C- - LO CO O L) -C- C co c? 1 c L - Ca) C O L .D -04 0 Lo- . .) 'n - - - rD -- -) LO -04 1 cD ca) -;I- -D (D -;- -;I- cc co -O co CV) (Dc LO) D -;I- cD LR CO C? 4 CO L C- C\ o ? c CO LO 00 y,) C) 00 M 'U) (cc 00 .;1- C14 -o MC - r- M (Dc (D C14 L cD LO - - ) L ) L -;I- - cc L ) C) mC) c -C L C? C | C C? L - L c) m oo a) co co co Lo N- C4 e- o -j- CO C co C c N- - c cc a o -c N- co N- 1 -N -N- N- C\) CO CO) L) L -~ LN L) D - -;I - D - -;- - r- - - -- U) M O O U U -;- r -) L cc cc (D Ma 00 '-;1 M - 04 ) M LO 04 00 00 LO cc - O -D D M c>i 1 c L> c- o co co -: -6 c .0 c - -r- 1 rc 1 c r- - -- r c 1 o 0c coL CO- C 0 00

--------------------------------------

- LU) C C 0 ~C)L[ L LU)) N- D -N- 04 LO cc ( - L0L e4 e - L- - -4 (6 r-- c yi- -) C-- - O - L 0 c c D m L - 00 co L? -I N- 0 cc C- L L - L CO C- C U L ) M O - L- N- -U N- L0 -- 04 04 ULL C) CO O) LO o co -N - 0 04 -;I -;I L' -;-- L Co Lo -y CaC Ca - U) a)I- L 04 CO CO -) 0 - - 04 C) LD c - a) C LC) Cx L ) L0L LC) C-4 -D mt cD D C) -D Lo C); C- C- m C;- - LO - cc -c------- - - - -N - - - - N- ------ - U) '-;I- - - 04 ' ( c o c C) - 0 LO U) c C1 U) - -;j: 1y 1i L6 o6 r-16 C O L y i M LO) CO O m c m co co cq- rc. co ci r o ai co o: L6 o6 q ; o y - co -O o Lo -a) -o ) -- (D (D U' - U)- -;U) -( - - - LO) LO L r -U a)D L--,L-- ,L- -L - L- - , C -0 -cy) c* - ~Cc c* [.D o6 - U C) - -cc co Cq4 Co4 - C)r -) cc c ri- r 0 - N- 0- (D -o -) O 00 c-~ r) C-4 -cc -a) -- e c c . c C" r-- m cc1 N- -N- -) cc) cU) qt) N-m U)4 m) -o N5 - a)N <.o -U) aC4 C) C) qt) 1*- a) N- a)MU' CD) -4 --. CO 1- ~Cc mC -04 a) -o N- a)o Cc4 C'4 m V04 4= / -c L' 0 0 M 5j (N~c OU0 -~~O~N~0C ) 00 <~ < <C C OQ f ~- < <~CO< - - CO< I < 0) < ~C <) CC Lm<0<0 - ~ C 0 - --- a - co s-~o~ c a )C coo -Uo U) c--r c- - o L LO L6 F.- U ) CO '6 -6 D (D L -D Lo (D ( D (D r D c o ca-cec6; co c L6 r r- Ir- U) -D -U) DO r- r- cD cD 00 - O M- LOC)MC) MC La) C) U) - o r -a r- -N- - - LO r C) r ) 00 - tD o LO -- Lr L e C COC L L) 04 CO e Ca LO U) U)4 00 -;1 c LO r- (D - r- - -0 DLO LO LO LO D( DL O Icc CN llz U) C04 C4 I-cc I-cc U, c) (D LO( O L D L - - co c C a -- co cc U) (D c O -U)- '- 'CO I- r o LO L L- -Cc LO Lc a, Ul L LC cd cr r- 0) C) M0 CO- 4= ~) U L- U) -C -U C.0 L- -- -to L L . . c4 1 - co -- - - C ) rD-O( - Cc) U'Cc ( C' C.) 4= cc O D jD O O ot LO o LO LO co 'r- a? U) 04 (D U) cCc* - -V- CO 4= -M 6> O q- L -- cc C-- 'C d C-C I -r -C C C) o c U) eO - UO CO U, -"m ' r- r- LO e- LO O OIt Intc L -0- CO c e -r- -c " " V. qct) SEO C-E) C-E) C-1 CE) C--C L4 04 CO Cc .. to I*- CO 4= I* 4 4= ' 4 6 - C-o cc cO LO LO c co cc cc -co co co ) - co co I*- co I - " I CO U U') " Ur -R 4= to to m LU E E C) L) 0CE L ...... - - - -C - - - -U - - - - - -- - - - - - - -- - ~ ------ - - - -.... ... ..... - -Ca O Example 4: Identification of domains comprised in polypeptide sequences useful in performing the methods of the invention The Integrated Resource of Protein Families, Domains and Sites (InterPro) database is an integrated interface for the commonly used signature databases for text- and sequence 5 based searches. The InterPro database combines these databases, which use different methodologies and varying degrees of biological information about well-characterized proteins to derive protein signatures. Collaborating databases include SWISS-PROT, PROSITE, TrEMBL, PRINTS, ProDom and Pfam, Smart and TIGRFAMs. Pfam is a large collection of multiple sequence alignments and hidden Markov models covering many J common protein domains and families. Pfam is hosted at the Sanger Institute server in the United Kingdom. Interpro is hosted at the European Bioinformatics Institute in the United Kingdom. The results of the InterPro scan of the polypeptide sequence as represented by SEQ ID NO: 5 2 are presented in Table C1. Table Cl: InterPro scan results (major accession numbers) of the polypeptide sequence as represented by SEQ ID NO: 2. InterPro Accession Reference Accession number in Name of e-value [amino acid coordinates of the number database reference database domain domain in the query polypeptide] IPR003851 PFAM PF02701 zf-Dof 2.2e-39 [48-110]T PROFILE PS50884 ZFDOF_2 28.910 [53-107]T PROSITE PS01361 ZFDOF_1 8e-5 [55-91]T 0 The results of the InterPro scan of the polypeptide sequence as represented by SEQ ID NO: 50 are presented in Table C2. Table C2: InterPro scan results (major accession numbers) of the polypeptide sequence as represented by SEQ ID NO: 50. The amino acid coordinates (start and stop residues) are 5 indicated. Database Accession number Accession name Amino acid coordinates on SEQ ID NO 50 HMMPfam PF00249 MybDNA-binding T[1 4-61] 4.3E-9 T[67-112] 1.1 E- 10 HMMSmart SM00717 SANT T[13-63] 1.3E-13 T[66-114] 1.8E-17 ProfileScan PS00037 MYB_1 T[17-25] 0.0 84 6022075_1 (GHMatters) P83714.AU.1 LEOWNR ProfileScan PS00334 MYB_2 T[89-112] 0.0 ProfileScan PS50090 MYB_3 T[9-61] 17.269 T[62-112] 16.619 Superfamily SSF46689 Homeodomainlike T[14-62] 4.31 E-17 T[63-116] 4.99E-15 Example 5: Cloning of the nucleic acid sequence used in the methods of 5 the invention The nucleic acid sequence used in the methods of the invention was amplified by PCR using as template a custom-made Arabidopsis thaliana seedlings cDNA library (in pCMV Sport 6.0; Invitrogen, Paisley, UK). PCR was performed using Hifi Taq DNA polymerase in standard conditions, using 200 ng of template in a 50 pl PCR mix. The primers used were J Primer-sense as presented by SEQ ID NO: 44; sense): 5'-ggggacaagtttgt acaaaaaagcaggcttaaacaatggatacggctcagtgg-3' and Primer-reverse (SEQ ID NO: 45; reverse, complementary): 5'-ggggaccactttgt acaagaaagctgggtaccgagaaattaattagcacc-3', which include the AttB sites for Gateway recombination. The amplified PCR fragment was 5 purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombines in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an "entry clone", pSEQlDNO:1. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway@ technology. The entry clone comprising SEQ ID NO: 1 was then used in an LR reaction with a destination vector used for Oryza sativa transformation. This vector contained as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR in vivo recombination with the 5 nucleic acid sequence of interest already cloned in the entry clone. A rice WS118 promoter (SEQ ID NO: 47) for seed specific expression was located upstream of this Gateway cassette. After the LR recombination step, the resulting expression vector pWS118::SEQDNO:1 M0 (Figure 4) was transformed into Agrobacterium strain LBA4044 according to methods well known in the art. 85 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Example 6: Topology prediction of the polypeptide sequences useful in performing the methods of the invention TargetP 1.1 predicts the subcellular location of eukaryotic proteins. The location assignment is based on the predicted presence of any of the N-terminal pre-sequences: chloroplast 5 transit peptide (cTP), mitochondrial targeting peptide (mTP) or secretory pathway signal peptide (SP). Scores on which the final prediction is based are not really probabilities, and they do not necessarily add to one. However, the location with the highest score is the most likely according to TargetP, and the relationship between the scores (the reliability class) may be an indication of how certain the prediction is. The reliability class (RC) ranges from 1 J to 5, where 1 indicates the strongest prediction. TargetP is maintained at the server of the Technical University of Denmark. For the sequences predicted to contain an N-terminal presequence a potential cleavage site can also be predicted. 5 A number of parameters were selected, such as organism group (non-plant or plant), cutoff sets (none, predefined set of cutoffs, or user-specified set of cutoffs), and the calculation of prediction of cleavage sites (yes or no). J The results of TargetP 1.1 analysis of the polypeptide sequence as represented by SEQ ID NO: 50 are presented Table D1. The "plant" organism group has been selected, no cutoffs defined, and the predicted length of the transit peptide requested. The subcellular localization of the polypeptide sequence as represented by SEQ ID NO: 50 may be the cytoplasm or nucleus, no transit peptide is predicted. 5 Table D1: TargetP 1.1 analysis of the polypeptide sequence as represented by SEQ ID NO: 50 Length (AA) 269 Chloroplastic transit peptide 0.195 Mitochondrial transit peptide 0.082 Secretory pathway signal peptide 0.022 Other subcellular targeting 0.914 Predicted Location / Reliability class 2 Predicted transit peptide length / 86 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Many other algorithms can be used to perform such analyses, including: - ChloroP 1.1 hosted on the server of the Technical University of Denmark; - Protein Prowler Subcellular Localisation Predictor version 1.2 hosted on the server of 5 the Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia; - PENCE Proteome Analyst PA-GOSUB 2.5 hosted on the server of the University of Alberta, Edmonton, Alberta, Canada; - TMHMM, hosted on the server of the Technical University of Denmark 3 Example 7: Functional assay for the MYB7 polypeptide MYB7 protein activity can be assayed as described by Li and Parish (1995). Briefly, the MYB7 coding sequence is cloned in frame with the T7 gene 10 leader sequence and expressed in E. coli. The proteins are purified and analysed in a mobility retardation assay, using 32 P-labeled c-myb binding site (MBS) and the binding site of the maize P gene product 5 (PBS). In this way, it was shown that MYB7 from Arabidopsis thaliana did not bind to the MBS site with high affinity, but had a binding preference for the PBS site. Example 8: Cloning of the nucleic acid sequence used in the methods of the invention J The nucleic acid sequence used in the methods of the invention was amplified by PCR using as template a custom-made Arabidopsis thaliana seedlings cDNA library (in pCMV Sport 6.0; Invitrogen, Paisley, UK). PCR was performed using Hifi Taq DNA polymerase in standard conditions, using 200 ng of template in a 50 pl PCR mix. The primers used were prm05966 (SEQ ID NO: 51; sense, start codon in bold): 5 5'-ggggacaagtttgtacaaaaaagcaggcttaaacaatgggaagatctccttgctg-3' and prm05967 (SEQ ID NO: 52; reverse, complementary): 5'-ggggaccactttgt acaagaaagctgggt catttattt cattt ccaagctt c-3', which include the AttB sites for Gateway recombination. The amplified PCR fragment was purified also using standard methods. The first step of the Gateway procedure, the BP 30 reaction, was then performed, during which the PCR fragment recombines in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an "entry clone", pMYB7. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway* technology. 87 6022075_1 (GHMatters) P83714.AU.1 LEOWNR The entry clone comprising SEQ ID NO: 49 was then used in an LR reaction with the destination vector p00640 used for Oryza sativa (japonica cv Nipponbare) transformation. This vector contained as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR 5 in vivo recombination with the nucleic acid sequence of interest already cloned in the entry clone. A rice GOS2 promoter (SEQ ID NO: 53) for constitutive expression was located upstream of this Gateway cassette. After the LR recombination step, the resulting expression vector pGOS2::MYB7 (Figure 8) J was transformed into Agrobacterium strain LBA4044 according to methods well known in the art. Example 9: Plant transformation 5 Rice transformation The Agrobacterium containing the expression vector was used to transform Oryza sativa plants. Mature dry seeds of the rice japonica cultivar Nipponbare were dehusked. Sterilization was carried out by incubating for one minute in 70% ethanol, followed by 30 minutes in 0.2% HgCl 2 , followed by a 6 times 15 minutes wash with sterile distilled water. D The sterile seeds were then germinated on a medium containing 2,4-D (callus induction medium). After incubation in the dark for four weeks, embryogenic, scutellum-derived calli were excised and propagated on the same medium. After two weeks, the calli were multiplied or propagated by subculture on the same medium for another 2 weeks. Embryogenic callus pieces were sub-cultured on fresh medium 3 days before co-cultivation 5 (to boost cell division activity). Agrobacterium strain LBA4404 containing the expression vector was used for co-cultivation. Agrobacterium was inoculated on AB medium with the appropriate antibiotics and cultured for 3 days at 280C. The bacteria were then collected and suspended in liquid co-cultivation 30 medium to a density (ODoo) of about 1. The suspension was then transferred to a Petri dish and the calli immersed in the suspension for 15 minutes. The callus tissues were then blotted dry on a filter paper and transferred to solidified, co-cultivation medium and incubated for 3 days in the dark at 250C. Co-cultivated calli were grown on 2,4-D-containing medium for 4 weeks in the dark at 280C in the presence of a selection agent. During this 35 period, rapidly growing resistant callus islands developed. After transfer of this material to a regeneration medium and incubation in the light, the embryogenic potential was released 88 6022075_1 (GHMatters) P83714.AU.1 LEOWNR and shoots developed in the next four to five weeks. Shoots were excised from the calli and incubated for 2 to 3 weeks on an auxin-containing medium from which they were transferred to soil. Hardened shoots were grown under high humidity and short days in a greenhouse. 5 Approximately 35 independent TO rice transformants were generated for one construct. The primary transformants were transferred from a tissue culture chamber to a greenhouse. After a quantitative PCR analysis to verify copy number of the T-DNA insert, only single copy transgenic plants that exhibit tolerance to the selection agent were kept for harvest of T1 seed. Seeds were then harvested three to five months after transplanting. The method J yielded single locus transformants at a rate of over 50 % (Aldemita and Hodges1996, Chan et al. 1993, Hiei et al. 1994). Corn transformation Transformation of maize (Zea mays) is performed with a modification of the method 5 described by Ishida et al. (1996) Nature Biotech 14(6): 745-50. Transformation is genotype dependent in corn and only specific genotypes are amenable to transformation and regeneration. The inbred line A188 (University of Minnesota) or hybrids with A188 as a parent are good sources of donor material for transformation, but other genotypes can be used successfully as well. Ears are harvested from corn plant approximately 11 days after J pollination (DAP) when the length of the immature embryo is about 1 to 1.2 mm. Immature embryos are cocultivated with Agrobacterium tumefaciens containing the expression vector, and transgenic plants are recovered through organogenesis. Excised embryos are grown on callus induction medium, then maize regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are 5 incubated in the light at 25 OC for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to maize rooting medium and incubated at 25 OC for 2-3 weeks, until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. 30 Wheat transformation Transformation of wheat is performed with the method described by Ishida et al. (1996) Nature Biotech 14(6): 745-50. The cultivar Bobwhite (available from CIMMYT, Mexico) is commonly used in transformation. Immature embryos are co-cultivated with Agrobacterium 35 tumefaciens containing the expression vector, and transgenic plants are recovered through organogenesis. After incubation with Agrobacterium, the embryos are grown in vitro on 89 6022075_1 (GHMatters) P83714.AU.1 LEOWNR callus induction medium, then regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are incubated in the light at 25 OC for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to rooting medium and incubated at 25 OC for 2-3 weeks, until 5 roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. Soybean transformation J Soybean is transformed according to a modification of the method described in the Texas A&M patent US 5,164,310. Several commercial soybean varieties are amenable to transformation by this method. The cultivar Jack (available from the Illinois Seed foundation) is commonly used for transformation. Soybean seeds are sterilised for in vitro sowing. The hypocotyl, the radicle and one cotyledon are excised from seven-day old young seedlings. 5 The epicotyl and the remaining cotyledon are further grown to develop axillary nodes. These axillary nodes are excised and incubated with Agrobacterium tumefaciens containing the expression vector. After the cocultivation treatment, the explants are washed and transferred to selection media. Regenerated shoots are excised and placed on a shoot elongation medium. Shoots no longer than 1 cm are placed on rooting medium until roots develop. The J rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. Rapeseed/canola transformation 5 Cotyledonary petioles and hypocotyls of 5-6 day old young seedling are used as explants for tissue culture and transformed according to Babic et al. (1998, Plant Cell Rep 17: 183-188). The commercial cultivar Westar (Agriculture Canada) is the standard variety used for transformation, but other varieties can also be used. Canola seeds are surface-sterilized for in vitro sowing. The cotyledon petiole explants with the cotyledon attached are excised from M0 the in vitro seedlings, and inoculated with Agrobacterium (containing the expression vector) by dipping the cut end of the petiole explant into the bacterial suspension. The explants are then cultured for 2 days on MSBAP-3 medium containing 3 mg/I BAP, 3 % sucrose, 0.7 % Phytagar at 23 0 C, 16 hr light. After two days of co-cultivation with Agrobacterium, the petiole explants are transferred to MSBAP-3 medium containing 3 mg/I BAP, cefotaxime, 35 carbenicillin, or timentin (300 mg/I) for 7 days, and then cultured on MSBAP-3 medium with cefotaxime, carbenicillin, or timentin and selection agent until shoot regeneration. When the 90 6022075_1 (GHMatters) P83714.AU.1 LEOWNR shoots are 5 - 10 mm in length, they are cut and transferred to shoot elongation medium (MSBAP-0.5, containing 0.5 mg/I BAP). Shoots of about 2 cm in length are transferred to the rooting medium (MSO) for root induction. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent 5 and that contain a single copy of the T-DNA insert. Alfalfa transformation A regenerating clone of alfalfa (Medicago sativa) is transformed using the method of (McKersie et al., 1999 Plant Physiol 119: 839-847). Regeneration and transformation of J alfalfa is genotype dependent and therefore a regenerating plant is required. Methods to obtain regenerating plants have been described. For example, these can be selected from the cultivar Rangelander (Agriculture Canada) or any other commercial alfalfa variety as described by Brown DCW and A Atanassov (1985. Plant Cell Tissue Organ Culture 4: 111 112). Alternatively, the RA3 variety (University of Wisconsin) has been selected for use in 5 tissue culture (Walker et al., 1978 Am J Bot 65:654-659). Petiole explants are cocultivated with an overnight culture of Agrobacterium tumefaciens C58C1 pMP90 (McKersie et al., 1999 Plant Physiol 119: 839-847) or LBA4404 containing the expression vector. The explants are cocultivated for 3 d in the dark on SH induction medium containing 288 mg/ L Pro, 53 mg/ L thioproline, 4.35 g/ L K2SO4, and 100 pm acetosyringinone. The explants are J washed in half-strength Murashige-Skoog medium (Murashige and Skoog, 1962) and plated on the same SH induction medium without acetosyringinone but with a suitable selection agent and suitable antibiotic to inhibit Agrobacterium growth. After several weeks, somatic embryos are transferred to BOi2Y development medium containing no growth regulators, no antibiotics, and 50 g/ L sucrose. Somatic embryos are subsequently germinated on half 5 strength Murashige-Skoog medium. Rooted seedlings were transplanted into pots and grown in a greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. Cotton transformation 30 Cotton is transformed using Agrobacterium tumefaciens according to the method described in US 5,159,135. Cotton seeds are surface sterilised in 3% sodium hypochlorite solution during 20 minutes and washed in distilled water with 500 pg/ml cefotaxime. The seeds are then transferred to SH-medium with 50pg/ml benomyl for germination. Hypocotyls of 4 to 6 days old seedlings are removed, cut into 0.5 cm pieces and are placed on 0.8% agar. An 35 Agrobacterium suspension (approx. 108 cells per ml, diluted from an overnight culture transformed with the gene of interest and suitable selection markers) is used for inoculation 91 6022075_1 (GHMatters) P83714.AU.1 LEOWNR of the hypocotyl explants. After 3 days at room temperature and lighting, the tissues are transferred to a solid medium (1.6 g/I Gelrite) with Murashige and Skoog salts with B5 vitamins (Gamborg et al., Exp. Cell Res. 50:151-158 (1968)), 0.1 mg/I 2,4-D, 0.1 mg/I 6 furfurylaminopurine and 750 pg/ml MgCL2, and with 50 to 100 pg/ml cefotaxime and 400 5 500 pg/ml carbenicillin to kill residual bacteria. Individual cell lines are isolated after two to three months (with subcultures every four to six weeks) and are further cultivated on selective medium for tissue amplification (300C, 16 hr photoperiod). Transformed tissues are subsequently further cultivated on non-selective medium during 2 to 3 months to give rise to somatic embryos. Healthy looking embryos of at least 4 mm length are transferred to J tubes with SH medium in fine vermiculite, supplemented with 0.1 mg/I indole acetic acid, 6 furfurylaminopurine and gibberellic acid. The embryos are cultivated at 300C with a photoperiod of 16 hrs, and plantlets at the 2 to 3 leaf stage are transferred to pots with vermiculite and nutrients. The plants are hardened and subsequently moved to the greenhouse for further cultivation. 5 Example 10: Phenotypic evaluation procedure 7.1 Evaluation setup Approximately 35 independent TO rice transformants were generated. The primary transformants were transferred from a tissue culture chamber to a greenhouse for growing J and harvest of T1 seed. Six events, of which the T1 progeny segregated 3:1 for presence/absence of the transgene, were retained. For each of these events, approximately 10 T1 seedlings containing the transgene (hetero- and homo-zygotes) and approximately 10 T1 seedlings lacking the transgene (nullizygotes) were selected by monitoring visual marker expression. The transgenic plants and the corresponding nullizygotes were grown side-by 5 side at random positions. Greenhouse conditions were of shorts days (12 hours light), 280C in the light and 220C in the dark, and a relative humidity of 70%. Plants grown under non stress conditions were watered at regular intervals to ensure that water and nutrients were not limiting and to satisfy plant needs to complete growth and development. Four T1 events were further evaluated in the T2 generation following the same evaluation procedure as for the T1 generation but with more individuals per event. From the stage of sowing until the stage of maturity the plants were passed several times through a digital 35 imaging cabinet. At each time point digital images (2048x1536 pixels, 16 million colours) were taken of each plant from at least 6 different angles. 92 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Drought screen in connection with DOF-C2 domain transcription factor polypeptides was performed as follows: Progeny of rice plants transformed with pWSI18::SEQIDNO:1 and grown from T2 seeds are 5 grown in potting soil under normal conditions until they approached the heading stage. They were then transferred to a "dry" section where irrigation was withheld. Humidity probes were inserted in randomly chosen pots to monitor the soil water content (SWC). When SWC went below certain thresholds, the plants were automatically re-watered continuously until a normal level was reached again. The plants were then re-transferred again to normal J conditions. The rest of the cultivation (plant maturation, seed harvest) was the same as for plants not grown under abiotic stress conditions. Growth and yield parameters are recorded as detailed for growth under normal conditions. Nitrogen use efficiency screen in connection with DOF-C2 domain transcription factor 5 polypeptides was performed as follows: Progeny of rice plants transformed with pWS118::SEQIDNO:1 and grown T2 seeds are grown in potting soil under normal conditions except for the nutrient solution. The pots were watered from transplantation to maturation with a specific nutrient solution containing reduced N nitrogen (N) content, usually between 7 to 8 times less. The rest of the cultivation J (plant maturation, seed harvest) was the same as for plants not grown under abiotic stress. Growth and yield parameters are recorded as detailed for growth under normal conditions. Drought screen in connection with MYB7 polypeptides is performed as follows: Progeny of rice plants transformed with pGOS2::MYB7 and grown from T2 seeds are grown 5 in potting soil under normal conditions until they approach the heading stage. They are then transferred to a "dry" section where irrigation is withheld. Humidity probes are inserted in randomly chosen pots to monitor the soil water content (SWC). When SWC goes below certain thresholds, the plants are automatically re-watered continuously until a normal level is reached again. The plants are then re-transferred again to normal conditions. The rest of M0 the cultivation (plant maturation, seed harvest) is the same as for plants not grown under abiotic stress conditions. Growth and yield parameters are recorded as detailed for growth under normal conditions. Nitrogen use efficiency screen in connection with MYB7 polypeptides is performed as 15 follows: 93 6022075_1 (GHMatters) P83714.AU.1 LEOWNR Progeny of rice plants transformed with pGOS2::MYB7 and grown from T2 seeds are grown in potting soil under normal conditions except for the nutrient solution. The pots are watered from transplantation to maturation with a specific nutrient solution containing reduced N nitrogen (N) content, usually between 7 to 8 times less. The rest of the cultivation (plant 5 maturation, seed harvest) is the same as for plants not grown under abiotic stress. Growth and yield parameters are recorded as detailed for growth under normal conditions. 7.2 Statistical analysis: F test A two factor ANOVA (analysis of variants) was used as a statistical model for the overall J evaluation of plant phenotypic characteristics. An F test was carried out on all the parameters measured of all the plants of all the events transformed with the gene of the present invention. The F test was carried out to check for an effect of the gene over all the transformation events and to verify for an overall effect of the gene, also known as a global gene effect. The threshold for significance for a true global gene effect was set at a 5% 5 probability level for the F test. A significant F test value points to a gene effect, meaning that it is not only the mere presence or position of the gene that is causing the differences in phenotype. Because two experiments with overlapping events were carried out, a combined analysis D was performed. This is useful to check consistency of the effects over the two experiments, and if this is the case, to accumulate evidence from both experiments in order to increase confidence in the conclusion. The method used was a mixed-model approach that takes into account the multilevel structure of the data (i.e. experiment - event - segregants). P values were obtained by comparing likelihood ratio test to chi square distributions. 5 7.3 Parameters measured Biomass-related parameter measurement From the stage of sowing until the stage of maturity the plants were passed several times through a digital imaging cabinet. At each time point digital images (2048x1536 pixels, 16 M0 million colours) were taken of each plant from at least 6 different angles. The plant aboveground area (or leafy biomass) was determined by counting the total number of pixels on the digital images from aboveground plant parts discriminated from the background. This value was averaged for the pictures taken on the same time point from the different angles and was converted to a physical surface value expressed in square mm 35 by calibration. Experiments show that the aboveground plant area measured this way correlates with the biomass of plant parts above ground. The above ground area is the area 94 6022075_1 (GHMatters) P83714.AU.1 LEOWNR measured at the time point at which the plant had reached its maximal leafy biomass. The early vigour is the plant (seedling) aboveground area three weeks post-germination. Increase in root biomass is expressed as an increase in total root biomass (measured as maximum biomass of roots observed during the lifespan of a plant); or as an increase in the 5 root/shoot index (measured as the ratio between root mass and shoot mass in the period of active growth of root and shoot). Early vigour was determined by counting the total number of pixels from aboveground plant parts discriminated from the background. This value was averaged for the pictures taken on J the same time point from different angles and was converted to a physical surface value expressed in square mm by calibration. The results described below are for plants three weeks post-germination. Seed-related parameter measurements 5 The mature primary panicles were harvested, counted, bagged, barcode-labelled and then dried for three days in an oven at 370C. The panicles were then threshed and all the seeds were collected and counted. The filled husks were separated from the empty ones using an air-blowing device. The empty husks were discarded and the remaining fraction was counted again. The filled husks were weighed on an analytical balance. The number of filled J seeds was determined by counting the number of filled husks that remained after the separation step. The total seed yield was measured by weighing all filled husks harvested from a plant. Total seed number per plant was measured by counting the number of husks harvested from a plant. Thousand Kernel Weight (TKW) is extrapolated from the number of filled seeds counted and their total weight. The Harvest Index (HI) in the present invention is 5 defined as the ratio between the total seed yield and the above ground area (mm 2 ), multiplied by a factor 106. The total number of flowers per panicle as defined in the present invention is the ratio between the total number of seeds and the number of mature primary panicles. The seed fill rate as defined in the present invention is the proportion (expressed as a %) of the number of filled seeds over the total number of seeds (or florets). Example 11: Results of the phenotypic evaluation of the transgenic plants The results of the evaluation of transgenic rice plants expressing a DOF-C2 transcription factor nucleic acid under the control of WSI 18 promoter (SEQ ID NO: 47) or under the RCc3 35 promoter as described in Table 2A. An increase of at least 5 % was observed in at least one 95 6022075_1 (GHMatters) P83714.AU.1 LEOWNR of the following parameters: emergence vigour (early vigour), total seed yield, total number of seeds, number of filled seeds, number of flowers per panicle and harvest index Performance of the plants transformed with vector pWS/18::SEQ/DNO:1 and grown under 5 non-stress conditions are presented below in Table D2. Table D2. Results of the phenotypic evaluation of the transgenic plants transformed with the plant transformation vector comprising SEQ ID NO:1 as described in Example 5. Yield-related trait % increased in transgenic versus control plants Early Vigour 9 Total Weight of Seeds 11 Number of filled seeds 12 Number of Flowers per panicle 6 Harvest Index 8 Number of total seeds 6 3 Example 12: Results of the phenotypic evaluation of the transgenic plants Evaluation of transgenic rice plants (the progeny of plants transformed with pGOS2::MYB7 and grown from T2 seeds) expressing a MYB7 nucleic acid under non-stress conditions revealed an overall increase of more than 5 % for aboveground biomass (AreaMax) with a p value of 0.0012, and for emergence vigour (early vigour) with a p-value lower than 0.00001. 5 96 6022075_1 (GHMatters) P83714.AU.1 LEOWNR

Claims (21)

1. A method for enhancing yqid-reated radt by modulaing expression in a plant of a nucdeic acid encoding a DOF-C2 domain transcription factor poWypeptide or a MYB-domairi protein 5

2. A rnelhod according o claim 1 for enhancing yield-related tra;s in plants relative to control plants, comprising modulating expression a) in a plani nucleic acid encoding a DOF-C2 (DNA-binding with one finger, subgroup C2) domain transcriphon 'actor poiypeptide comprising feature (i) and feature (3) as follow 10 (i)a DOF domin having i increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 96%, 97%, % 99% or more sequence identity to Wther the DOF domain represented by SEQ ID NO: 35 or SEQ ID NO: 36' and (fi)Moif : ER KARPOKOQ (SEQ ID NO: 37) having zero, one or more conservative amino acid substltution(s) and/or having in increasing order of preference five, four, three, two or one non 15 co nonraive arrno aid u bstitu)itions); an d/or Motif II: YWSGMI (SEO ID NO: 38) having zero, one or more conservative amino acid subtitulons an&or having in increasing order of preference three, two or one non-conservative ammno acid substitutition~s) or ) In a plantof a nucleic acid encoding a MYB7 polypeplide, wheretn said MYB7 polypeptide O comprises a two SANT domains

3, Method according to claim 2, wherein a) said DOF-C2 transcrpliodfactor polypeptde furthermore comprises one, two, 1hree, for or all of the fonowing motifs: 25 Motif 1ll: RLLEFPFEDLKPLVS (SEO ID NO: 39) having zero, one or more conservative amino acid substilutionts) and/or having in increasing order of preference five, four, three, hw or one non-on servative amno acid stbstiuition(s); and/or Motif IV:ZINVKPMEFI (SEQ ID NO: 40) having zero, one or more conservative amino acid substiMionfs) and/or having in increasing order of preference four, three, two or one non' 30 conservative arrm actd substitition(s): and/or Met V: KNPRLLHEGAQDLNLAFPHH (SEQ ID NO: 41) having zero, one or more conservative amino add substitution(s) and/or having in increasing order of preference nine, eight, seven, six, five, four, three, two or one non-conservative amino add substitutition(s): and/or 35 Moif V: MELLR$TGCYM (SEO ID NO: 42) having zero, one or more conservative amino acid subslliudon(s) and/or having in increasing order of preference five, four, three, two or one non conservative amino acid substituitions): and/or Motif Vi: &MSNSVLYSSLGFPTMPDYK (SEQ tD NO: 43 having zero, one or more conservative amino acid substution(s) andor having in increasing order of preference nine, eight. seven, six, five, four, three, Iwo orone orconservaive amino acd subslution(s) or b) said MYS? poiyrptide comprises four or more of the motifs 1 to 7 (SEQ ID NO: 55 5 SEQD NO: 61).

4, Mehod according to claim 2 or 3, wherein said modulated expression is effected by introducing and expressing in a plan a nucleic acid encoding a DOF-C2 transcription fctor polypeptide or a nuclec acid encodrng a MYB7 polypepide.

5. Method according to claims 24, wherein a) said nucleic acid encoding a DOF-C2 transcription factor polypeptide encodes any one of the proteins listed in Table Al or is a portion of such a nucleic acid, or a nucleic acid capable of hybridising with such a nucleic acid or 15 b) said nucleic acid encodinga MYB7 potypepfide encodes ay one of the proteins listed Table A2 or is a portion of such a nucleic acdd, or a nucleic acid cap able of hyridising wdh such a nucleic acid.

6, Method according to to claims 2-5, wherein said nucleic acid sequence encodes an 20 orlthologue or paraiogue of any of the proteins given in Table Al or Table A2

7. Method according to lo clims 2-6, wherein said enhanced yieldrelated traits comprise a) nereased yield, preferably increased early vagour andior increased seed yield relative to control plants or U) Increased biomass and/or increased emergence vigour relai've to control 25 plants

8 Method according to dalms 2~7, wherein said enhanced yield4elated traits are obtained under norvstress conditions 30

9, Method according to to clairns 2-8, wherein said nucleic acid is operably linked to a) a seed specific promoter, preferably to a promoter of a gene encoding a late embryogenesis protein, most preferably to a WSI 18 promoter kon rice or b) a constitutive promoter, preferably to a GOS2 promoter, most preferably to a GOS2 promoter from rice, 35

10. Method according to to claims 2-9, wherein said nucleic acid encoding a 00FC2 transcription factor polypeptide or a MYO7 polypeptide is of plant origin. preferably from a d icotyldonus plant, further preferably forn the family Brassicaceae, more preferably from the genus Arabidopsks rnos! preferably from Arabidopsis thiara

11. Plant or part thereof, including seeds, obtainable by a method according to to claims 210, 5 wherein said plant or part thereof comprises a recomNbinant nucleic acid encoding a DOF-G2 transcption factor polypeptide or a MYB7 polypeptide,

12. Consiruct comprising: {i)nucieic acid encodng a DQF-C2 transcription factor polpeplide or a class MYB7 10 polypeptide as deined in cairns 3 or 4; {ii)one or more control sequences capable of diving express on of the nucleic acid sequence of (a); and oplonaily (iii)a tanscrp~on terraina ion sequence 15

13. Construct accorrtng to claim 12. wherein a) One of said control sequences is a seed-specific promoter, preferaby a promoter o1 a gene encoding a late embryogenesis protein, most preferably a the promoter of the rice WSi1 gene or b) one of said control sequences is a consecutive promoter, preferably a GOS2 promoter, most 20 preferably a GOS2 promoter from rice

14- Use of a construct according to claim 12 or 13 in a method for making plants having increased yield and a) particularly increased eady vigour and/or increased seed yield relaiveto control plants 25 or b) particularly increased biormass and/or increased emergence vigour relative to control plants.

15. Plant, plant part or plant cell transformed wIth a construct according to claIm 12 or 13 30

16. Method for the production of a transgenic plant having increased yield, particularly increased biomass and/or increased vigour and/or increased seed yield relative to control plants, comprising: (i)inlroducing and exPressing in a plant a nucteic acid encoding a DOF-C2 transcrlption factor polypeptide or a nucleic acid en coding a MYB7 poiypeptide as defined in claim 2 or 3; and 35 (ii)cultivating die plant cell under condions promoting plant growAh and development.

17. Trnagenic plant havingcreased yield, particularly increased biomass and/or irieased vigour and/or increased seed yield. relative to control plants resulting from modulated expression of' a nucdeic acid encedingj a DOR-C2 iranscriplion factor polypeptide or a MYB7 polyppNtide as dined in clair 2 or 31 or a transgenic plant cel derved Irom said transgenic 5 plant

18. Transgenic plant according 1o claim 11, 1S o 17, or a transgeric plant cel derswed thereof, wherein said plant is a crop pant or a monocot or a cereal such as rice, maize, wheat barley, mihet, Eye, triticale, sorghum and oats. 10

19. Harvestable parts of a plant according to claim 18, wherein said harvestable parts are preferably shool biomass and/or seeds or vegetative biomass,

20, Products derived from a pant according to clam 18 and/or from harvestable parts of a 15 plant according to claim 19,

21. use of a nucleic acid encoding a DCF-C2 transcription factor polypeptide or a MYB7 polypeptide in increasing plant yield, particularly in increasing seed yield and/or increasing biomass and/or vigour in plants, relative to control plants. 20